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Background: Home Health Care (HHC), the most commonly used bridge strategy for 
transitioning from hospital to home-based care, is expected to contribute to ongoing 
readmission avoidance efforts.  However, evidence suggests HHC patients are readmitted 
more frequently than patients without HHC. Determining the effectiveness of HHC as a 
readmission reduction strategy requires a comparison sample of patients with similar 
characteristics referred and not referred to HHC.  
 
Methods: For this matched-sample comparative study, the available sample 
(n=18,774) included 3,629 patients referred to HHC and 15,145 non-HHC patients, from 
which 2,718 pairs matched 1:1 were obtained using exact and Mahalanobis distance 
matching. Unadjusted two-sample test of proportion followed by multinomial logit 
regression analysis adjusting for residual sample differences compared, post-discharge 
return to hospital for readmissions and Emergency Department [ED]/Observation visits 
within 30 and 60-days post-discharge.  Post-hoc analyses using the same approach 
stratified the sample using the Elixhauser Comorbidity Index into high and low-
comorbidity groups.   
 
Results:  No statistically significant difference in readmissions or ED/Observation 
visits between HHC and non-HHC patients was observed, except for HHC-referred low-
comorbidity patients who had 2.2% higher 30-day ED/Observation visit rates.   
 
Conclusions:  Similarities in post-discharge utilization in this matched sample 
analysis is an improvement over prior observation studies where rates for HHC patients 
were at least 5 percentage points higher than non-HHC patients. The study results raise 
the question of why HHC services did not produce evidence of lower post-discharge 
return to hospital rates. Focused attention by HHC programs on strategies to reduce 
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CHAPTER I:  INTRODUCTION 
 
Chapter One includes the background of the study, statement of the problem, 
purpose of the study, significance of the study, research aims, questions, and hypothesis.    
Reduction in frequent and early readmissions is a national priority.  Acute care 
hospital readmissions have a significant impact on the lives of patients and are costly to 
payers (Centers for Medicare and Medicaid Services, 2016a).  The enactment of the 
Affordable Care Act (ACA) was an effort to connect payment of services with the quality 
of hospital care provided. As a measure of value of the care provided, early readmissions 
(within 30 days) may indicate a lapse in the quality of care provided (“Medicare Hospital 
Readmissions Reduction Program,” 2013). Recognizing the relationship between the 
quality of hospital and transitional care and readmissions, the Centers for Medicare and 
Medicaid Services (CMS) launched the Hospital Readmissions Reduction Program 
(HRRP) in FY 2013.  The HRRP is a program created to financially incentivize hospitals 
to decrease their readmission rates through reimbursement penalties. Initially, those 
diagnoses with particularly high readmission rates were targeted for reduction.  These 
diagnoses included Acute Myocardial Infarction (AMI), Heart Failure (HF), and 
Pneumonia (CMS, 2016a). In Fiscal Year 2015, the program was expanded to include 
Chronic Obstructive Pulmonary Disease (COPD) and Total Hip Arthroplasty 
(THA)/Total Knee Arthroplasty (TKA) in an effort to continue efforts to decrease 
readmissions (CMS, 2016a). Within these diagnoses, there is wide variation of rates of 





hospitals that care for Medicare beneficiaries 65 years and older. The most recently 
reported national readmission rate is 15.6% (CMS, 2016b). The problem does not only 
exist for hospital readmissions.  Similar problems as described for hospital readmissions 
also exists for Emergency Department (ED) visits.  Greater than 15% of ED visits in the 
US are from patients aged 65 years and older (Gill, Allore, Gahbauer, & Murphy, 2010), 
resulting in a similar focus on reducing ED visits within the Medicare population 
(Gernant, Snyder, Jaynes, Sutherland, & Zillich, 2016).  
The continued and increasing focus on reduction in readmissions and related costs 
have pushed hospitals and healthcare providers to consider a wide array of strategies to 
meet the demands of CMS programs. Despite implementation of a wide variety of post-
hospitalization support interventions, the outcome of reducing readmissions has shown 
mixed results (Leppin et al., 2014; Mattke, Han, Wilks, & Sloss, 2015; Naylor, Aiken, 
Kurtzman, Olds, & Hirschman, 2011; Wong et al., 2015).  In response, providers have 
turned to Home Health Care (HHC) as the most frequently used post-acute care strategy 
(Bowles et al., 2010).  The intent of the HHC strategy is to not only decrease costs 
through a decreased Length of Stay (LOS), but also decrease readmissions by extending 
care services to the home (S. L. Hughes et al., 1997).  The purpose of HHC is to offer 
patients the opportunity to convalesce in their home with the assistance of skilled care 
(Keepnews , Capitman, & Rosati, 2004).  Home Health Care provides assistance with 
medical care needs, surveillance of progress, and assessment of additional care needs that 
can anticipate and mitigate potential risks, reduce complications, adverse events and 
unplanned utilization including readmissions (Sanford et al., 2014a).  Despite post-acute 





patients receiving HHC services is higher than those who do not receive these services 
(Bowles & Cater, 2003; Feltner et al., 2014; Naylor & Sochalski, 2010), which can be 
attributed primarily to the higher level of acuity in patients who have received a HHC 
referral (Hughes, 2008).  Concerns about the acuity of patients receiving HHC and its 
relationship to recurrent Emergency Department visits (Gernant et al., 2016) are also 
reported.  For example, similar to hospital readmissions, CHF is identified as one of the 
most frequent diagnoses for recurrent ED visits followed by other chronic conditions 
(Neufeld, Viau, Hirdes, & Warry, 2016) such as chronic respiratory disease and acute 
cerebrovascular accidents (Latham & Ackroyd-Stolarz, 2014).  
The higher rate of readmissions and/or ED visits for patients with a HHC referral 
has spurred interest and subsequent research. Recent research has investigated care 
interventions to reduce readmissions including improved discharge services, coordinated 
multidisciplinary care team visits (Centeno & Kahveci, 2014), timeliness of follow-up 
care visits (Murtaugh et al., 2016), follow-up phone calls (Gernant et al., 2016; Wong et 
al., 2015), and enhanced clinical management including telehealth and digital health 
(Naylor et al., 2011).  However, the studies examining these interventions have not used 
sufficient controls to account for factors associated with variation in risk for readmissions 
and/or ED visits that may be attributable to non-HHC factors.  As a result, a lack of 
clarity remains on the overall effectiveness of the utilization of HHC to reduce post-
discharge utilization (readmissions and ED visits) as evidenced by conflicting literature 
on the outcomes of the intervention.  
The increased readmissions and ED visits for those patients referred to transition 





a post-acute care bridge strategy (Naylor et al., 2004).  The purpose of this research study 
was to determine, and subsequently inform the healthcare community and its consumers, 
the effectiveness of referral to Home Health Care in reducing post-discharge utilization.  
This was achieved by comparing patients with similar characteristics who have been 
discharged to home with and without referral to home health services.  
There is a knowledge gap in determining the effectiveness of HHC in reducing 
post-discharge utilizations.  Relevant research has not clearly and definitively studied the 
utilization outcome, using equal comparison groups to determine the success of the 
intervention as intended.  Without this information, the effectiveness and appropriateness 
of using HHC as an intervention to reduce post-discharge utilization remains unknown.  
Perpetuation of this gap may result in inappropriate referrals or non-referrals and 
subsequent post-discharge utilizations.  
 Additional research addressing the gaps of previous studies will contribute to the 
body of knowledge around the effectiveness of the utilization of HHC services to reduce 
post-discharge utilization.  Findings contribute to the decision-making processes of health 
care providers considering HHC referral for patients and could be used during both the 
discharge planning process as well as the discharge education process to better identify 
and plan for patients requiring post-acute care. The goal of this research was to 
investigate the effectiveness of using HHC as a post-acute care intervention to prevent 
post-discharge utilization occurrences and determine the existence of a relationship using 
improved methodology of equal comparison groups. The results of this study added to the 
body of knowledge regarding the use of HHC as a health care resource for the provision 





Statement of Significance 
Significance to practice.  The significance of this study to nursing practice was 
in the contribution nurses can make to the HHC referral process.  Referrals to HHC made 
by providers generally occur through the recommendation of other health care 
professionals caring for the patient (Bowles, Foust, & Naylor, 2003) such as Case 
Managers (CM) and Social Workers (SW).  Research suggests that nurses are least likely 
to refer patients to HHC (Bowles et al., 2003) despite the amount of time spent caring for 
the patient.  Since nurses spend the most time with the patient, they would be best suited 
to actively participate in post-discharge utilization reduction activities. Such activities 
may include completion of standardized tools upon admission to the hospital that 
contribute to discharge planning efforts.   
Research has identified that a structured standardized assessment tool such as the 
Discharge Decision Support System (D2S2)(Bowles et al., 2003; Bowles, Hanlon, 
Holland, Potashnik, & Topaz, 2015) that assists in appropriately identifying the need for 
post-discharge services (Bowles, Hanlon, Holland, Potahnik & Topaz, 2014) could help 
identify patients who require post-acute care services. A multidisciplinary approach to 
referrals (Boutwell, Johnson, & Watkins, 2016; Centeno & Kahveci, 2014) and the use of 
standardized tools can successfully integrate nursing judgment care coordination into the 
post-acute care referral process (Bowles et al., 2014).  The results of this study 
determining the effectiveness of HHC referral contribute to discharge practice by 
providing information on high-risk patient characteristics when considering referring 





Significance to health services research.  The significance of this study is the 
investigation of HHC effectiveness, which provided foundational evidence for designing 
health system strategies for referral of at-risk patients.  Ongoing development and 
understanding of guidelines for referral of at-risk patients to HHC have the potential to 
reduce the burden of illness from post-discharge complications and the resulting costs of 
care.   Current literature, however, suggests that the use of HHC is associated with higher 
rates of readmission (Li, Daldalian, Hunter, Sutariya, & Leung, 2016; Martin et al., 2011; 
Riggs, Roberts, Aronow, & Younan, 2010; Sanford et al., 2014b), and increased ED 
visits (Gernant et al., 2016)  when unadjusted for patient characteristics or when using a 
limited set of control variables such as those related to disease severity. This study 
utilized statistical methodology to control for bias in patient selection for referral to HHC 
by matching patients with like characteristics. The results of this study may be useful as a 
tool to enhance existing standardized HHC referral policies.   
It is increasingly important to consider the value of care provided to patients by 
all healthcare team members in light of the reimbursement challenges set forth by the 
CMS.  By evaluating the effectiveness of utilizing HHC to reduce post-discharge 
utilization, a conceptual starting point can be established for the successful 
implementation and utilization of HHC.  The appropriate contextual environment for 
understanding health outcomes can offer supportive and informed decision-making at the 
time of referral for appropriate utilization of this resource.   
The innovation of this study is that it uses data from a large scale multi-site study 
linking the intervention (HHC referral) to the outcome (post-discharge utilization) using 





patients receiving particular interventions within the course of care and treatment, but 
have not addressed the comparability of the two groups. This effectiveness study was the 
first to utilize equivalent comparison groups of patients who are referred to HHC and 
those who are not referred to evaluate the intervention (HHC referral) to the outcome 
(post-discharge utilization) providing an important opportunity to investigate the impact 
HHC referrals have on post-discharge utilization.  This research will benefit patients, 
families, caregivers, health care professionals and society through the evaluation of the 
effectiveness of HHC as a bridge strategy from hospital to home in preventing post-
discharge utilization. 
Significance to vulnerable populations.  This study is of great significance to 
the vulnerable aging population and individuals at risk for readmission to the acute care 
environment. Older adults have an increased risk of adverse health events (Bandeen-
Roche et al., 2015).  By 2050, the United States (US) population aged 65+ may reach 89 
million (Dall et al., 2013).  The growth of the elderly population in the US will create 
additional demands on the healthcare workforce due to a growing disease burden (Dall et 
al., 2013).  Current statistics indicate 1 in 5 Medicare beneficiaries (age 65+) will 
experience early readmissions (within 30 days of discharge) (“Medicare Hospital 
Readmissions Reduction Program,” 2013).  The combined elderly population growth 
projections and early readmission rates indicate that unless readmission reduction efforts 
are successful, the needs of the aging population can further stress the capabilities of the 
healthcare system to provide accessible and timely care thereby increasing the risk of an 





Significance to nursing education.  This study can be useful in nursing 
education in both the undergraduate and graduate levels.  As undergraduates, the 
importance of advocacy for effective discharge planning throughout the continuum of 
care can be underscored as students improve their understanding of their role on the 
healthcare team including how their active involvement in patient care can impact the 
decisions of the entire healthcare team.   
As undergraduate students, these future nurses can enhance their understanding of 
the continuum of care through an increased awareness of the transition from the hospital 
to HHC. Using the study results to elevate their level of understanding of the post-acute 
care, including risks and facilitators present during the transition to HHC, students can 
visualize the impact of their interventions from one level of care to the next. An improved 
understanding of the transition to home can help students, as future members of the 
healthcare team, increase awareness of their role in discharge and transition and how to 
prevent adverse events, such as readmissions, from occurring. It is important that nurses 
understand the value of their contributions and advocacy in the care of the patient and the 
contributions they make can impact decisions about referral to HHC. 
Graduate students, who are preparing for roles as Advanced Practice Nurses 
(APNs), will have an increased opportunity to be intimately involved in the referral 
process to HHC. Adult and acute care APNs continue to take on more responsibility for 
the provision of care and treatment of patients, which may include decision-making about 
post-acute care (Winne et al., 2012).  This study can provide future APNs with insight 
necessary to improve decision making when considering using HHC as a readmission 





option to reduce post-discharge utilization will contribute to the factors considered for 
determining the need for post-acute care services. 
Innovative strategies, such as interprofessional education and simulation can be 
used to facilitate learning of the role nurses and APNs play in the utilization of HHC and 
post-discharge utilization reduction. Whether an undergraduate or a graduate student, 
innovative teaching and learning strategies can be used to increase awareness of the 
essential elements considered when a patient is provided a referral to HHC as a part of 
their post-acute care. Simulated experiences involving multiple professions can increase 
the understanding of factors considered in a referral as well as the role in knowledge 
generation that each profession can, does, and should have in determining the optimal 
post-acute plan of care. 
Research Aims, Questions, and Hypothesis 
The following aim guided the design of the study.  
Aim:  To determine the effectiveness of HHC in reducing return to hospital after 
discharge  
Research Question (RQ):  What patient characteristics are associated with the 
initiation of a referral for HHC prior to hospital discharge?  The matched sample used to 
test the hypothesis was created using patient characteristics identified as associated with 
the initiation of a referral for HHC as ascertained from RQ1and accessible in the existing 





Hypothesis (H): When comparing patients referred to HHC with a comparable group 
of patients with the same characteristics not referred to HHC, patients who receive a 
referral will have fewer occurrences of post-discharge utilization occurrences within 30 
days and between 31 and 60 days after hospital discharge. 
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CHAPTER II: THEORY AND REVIEW OF THE LITERATURE 
 
 Chapter 2 presents a review of the literature, synthesizing the research on patient 
characteristics identified as high-risk for referral to HHC and post-discharge utilization 
(readmissions and ED visits), the relationship between Home Health Care (HHC), its 
health outcomes, and the risk of post-discharge utilization. This chapter further describes 
existing gaps within the literature, especially studies describing the outcomes of HHC 
and the potential moderators and mediators of its relationship to readmissions.  This 
chapter includes 1) philosophical underpinnings; 2) Conceptual, Theoretical, and 
Empirical (CTE) structure of the study; 3) assumptions of the study; 4) review of the 
literature on the effectiveness of HHC; and 5) a summary of gaps within the literature 
that justify the need for the proposed study.  
Philosophical Underpinnings 
This study investigates patient characteristics associated with receiving a HHC 
referral prior to discharge from the hospital and the existence of a relationship between 
Home Health Care (HHC) and post-discharge utilization through the secondary analysis 
of an existing database.  This study, as well as the parent study uses a post-positivist lens 
in considering how to approach the study of the effectiveness of HHC in reducing post-
discharge utilization.   
It is important to review positivism in order to better understand post-positivism and 
its connection with this study.  The Positivism movement was founded by Auguste 





how things appeared in nature (Comte, 1830).  Prior to Comte, the sciences were based 
on theology and metaphysics. Comte rebelled against these sciences believing they were 
subjective and true science was present in nature and observations of the nature of things 
would bring generalizable truth to science.  This required all studies of science to be free 
of any bias including human fallacy (Comte, 1830) and free from individual prejudices, 
influence on behavior, feelings, context and experiences (Crossan, 2003).  However, it 
was later determined that despite the importance of realism, the study of the nature of 
things without the influence of prior experience and feelings was not possible and as a 
result, post-positivism emerged.   
Post-positivism is similar to positivism, but takes into account the human experience.  
The fundamental belief of post-positivism is that the reality of nature does exist, but it is 
not possible for humans to fully observe because of the prior context that accompanies all 
observations.  The experiences and prejudices within a researcher are omnipresent and 
cannot be excluded (Guba, 1990) and there is no absolute knowledge (Racher & 
Robinson, 2002).  As a result, there is no absolute certainty.  There is only the best 
information that can be offered through recognition of human perceptions, how humans 
interact with their own social phenomena to produce outcomes, and the application of the 
methodological approach to study what best fits the nature of the research (Clark & 
Lissel, 2008).  It is essential for researchers to be forthright about the limitations and 
biases inherent in their research to the critical community (Guba, 1990).  Finally, critical 
multiplism is emphasized in post-positivism and is best achieved through the use of many 
sources of data on which to base the findings of the study, thereby increasing objectivity 





inability to reach objectivity because the human experience is always an influence 
(Allmark, 2003) and the knowledge obtained from studies can never be fully verified 
because humans cannot observe and experience everything (Guba, 1990).   
Using the post-positivist lens, the study of the effectiveness of the utility of HHC in 
reducing post-discharge utilization relies on the use of well-defined variables studied 
where attention is paid to controlling other influences on outcomes, using valid 
instrumentation, and empirical testing (Houghton, Hunter, & Meskell, 2012). In this 
study, a list of well-defined variables was created (Chapter 3, Table 1). Each of these 
variables fit within an associated concept in the theoretical framework (Chapter 2, Figure 
2), definition of its use in the study, and measurement specification.  An existing database 
of the parent study was used and the data contained within the database used valid and 
reliable instruments during the study period.  The results of these tools including the 
Patient Readiness for Hospital Discharge Scale (PTRHDS) short form and the READI 
nurse assessment form will be used as data elements for this study.  Finally, this study 
performed empirical testing of the observed data.  The identified outcomes of the study 
that were tested include post-discharge utilization within 30 and 60-days of initial 
discharge.  It is understood that, despite all attempts to eliminate bias, some limitations 
do exist and the results of this study only represents a partial truth with limited 
generalizability.   
Methodologically, this study uses a Post-positivistic lens in that it strives to achieve a 
reality as close to the reality of the concept of interest as possible (Houghton et al., 2012).  
Specifically, this study used exact matching and Mahalanobis distance matching to 





observable answer about the effectiveness of the utility of HHC in reducing post-
discharge utilization.  The importance of critical multiplism (Guba, 1990) was evident 
through the use of varied sources of data including Electronic Health Records (EHR), 
administrative data sources, and self-report instruments, thereby increasing the level of 
objectivity of the study.   
Finally, this study was open to the critical community through various modes.  This 
study is being completed through the guidance and close observation of a dissertation 
committee comprised of expert researchers.  The committee’s expertise provided the 
researcher with ongoing varied perspectives and suggestions to improve the rigor and 
validity of this study.  After the study is completed, all findings were disseminated to the 
larger community of peers through publication in relevant journals.  In the case of this 
study and its findings, the critical community is comprised of nursing educators, 
multidisciplinary healthcare providers, and hospital administrators in the fields of acute 
care, HHC, and other post-acute care settings.   
Conceptual-Theoretical-Empirical Structure 
 The purpose of the Conceptual-Theoretical-Empirical Structure (CTES) 
development is to identify theoretical linkages between theoretical concepts, concepts of 
interest in the present study, and empirical measures for these concepts.  It is a process of 
creating a model for the study of concepts of interest framed by an established conceptual 
model or theoretical framework (Fawcett, 1999).  This CTES describes the Home Health 
Care (HHC) referral process’ impact on post-discharge utilization within 30 and 60-days 





study. This CTES framework provided a research model linking theoretical concepts of 
interest to testable measures of the effectiveness referral to HHC as a post-acute 
intervention to reduce post-discharge utilization.   
Theoretical framework and rationale.  Transitions are multidimensional and 
incorporate the unique and complex circumstances present in the transition (Meleis, 
Sawyer, Im, Hilfinger-Messias, & Schumacher, 2000).  Within the constructs of Nature 
of Transitions, Transition Conditions:  Facilitators & Inhibitors, Patterns of Response, 
and Nursing Therapeutics, Transitions Theory uncovers the role that daily life activities, 
surroundings, and interactions have on a patient’s life, well-being, and relationships 
(Meleis et al., 2000).  Transitions Theory maintains that recognition of transitional phase 
and prompt intervention by the healthcare team can result in positive outcomes (Meleis et 
al., 2000). Transitions Theory was selected as the conceptual level theory for the study 
because of the compatibility of the concepts with the theoretical concepts of the Home 
Health Care referral process and the interaction of the patient with their post-acute care 






Figure 1: Meleis' Transitions Theory (Meleis et al., 2000) 
 According to Chick & Meleis (1986), transitions can be defined as “a period of 
change between two relatively stable states” (p. 253).  The Transitions theory has four 
main concepts: 1) Nature of Transitions including the type, pattern, and properties of the 
transition; 2) Transition Conditions:  Facilitators & Inhibitors, which include a personal, 
community, and societal relationship; 3) Patterns of Response including the process and 
outcome indicators of the response; and 4) Nursing Therapeutics, which are the actions of 
the care provider to support the patient during the transition (Meleis et al., 2000).    
Acute hospitalization with subsequent return to the community is one example of 
an individual entering a process of transition. The Nature of transition is the transition 
from acute care hospitalization to post-discharge care at home and is confounded by the 
patient characteristics (Transition Conditions:  Facilitators and Inhibitors), and progresses 





the patient is the healthcare team’s decision-making (Nursing Therapeutics) on the 
appropriateness of a post-acute care referral to HHC.   
 Fundamentally in the Transitions Theory, every transition has an entry point, 
passage through the transition, and an exit point. In the Home Health Care Referral 
Model (HHCRM) (see Chapter 2, Figure 2), which is the framework of concepts and 
relationships for this study derived from the conceptual level Transitions Theory, the 
precipitating event, or entry, for the transition is the discharge to home. At the time of 
discharge, there is an intervention by the acute care healthcare team represented by the 
decision to refer to home health care. The passage occurs during continued convalescence 
at home with or without HHC.  For this study, the culmination, or exit, of the transition 
occurs when the patient either is readmitted to the hospital, has an ED visit, or completes 







Figure 2: Home Health Care Referral Model (HHCRM) 
Horizontal structure.  The horizontal structure of the CTE demonstrates how the 
relationships proposed in the Transitions Theory (the conceptual level of the CTE) are 
represented in the proposed relationships in the study model (theoretical level) and 
operationalized as study hypotheses (the empirical level). The horizontal structure 
consists of interrelated concepts and properties, which were previously discussed.  
Transition Theory asserts that the Nature of Transitions has an influence on the 
Patterns of Response (Meleis et al., 2000). This relationship is expressed in the HHCRM 
concept of Discharge Transition to HHC has an influence on post-discharge utilization.  





organizational care model and hospital (organizational), prior admissions (patterns), and 
Length of Stay [LOS] (transition properties) are all precursors to the transition and the 
determination of a HHC referral decision.  These precursors are factors for post-discharge 
utilization, which will be measured to help determine their association with healthcare 
team referral to HHC.  In the HHCRM, it is proposed that the properties of discharge 
transition to HHC will have an increased positive effect on Healthcare Team 
Therapeutics: HHC referrals at the time of discharge.   
 In Transitions Theory, perceptions and meanings are influenced by the 
conditions of the transition (Meleis et al., 2000).  The concept of Personal: Facilitator and 
Inhibitors is associated with the initiation of a HHC referral and subsequently fewer post-
discharge utilizations.   The concept of patient characteristics, such as level of functional 
independence (Centeno & Kahveci, 2014; Holland & Bowles, 2012; Leppin et al., 2014) 
and age (Coleman, 2003; Murtaugh et al., 2016), have been shown to affect post-
discharge utilization (Bowles et al., 2008). It is proposed that patient characteristics are 
associated with the initiation of a HHC referral prior to discharge. 
 Patterns of response are influenced by Transition Conditions:  Facilitators & 
Inhibitors (Meleis et al., 2000). The concept of post-discharge utilization in the HHCRM 
is negatively associated with the Healthcare Team Therapeutics: HHC referral. HHC is 
frequently utilized as a bridge strategy to prevent readmissions from occurring (Bowles et 
al., 2010).  A comparison will be completed using comparable groups referred to HHC 
and not referred to HHC to determine if receiving a HHC referral results in fewer patients 






 Therapeutic interventions provided to the patient influence their Patterns of 
Response (Meleis et al., 2000). The concept of Healthcare Team Therapeutics: HHC 
referral in the HHCRM has a negative relationship with post-discharge utilization.  It is 
proposed that the group of patients who received a referral would have less post-
discharge utilization than the group without a referral. 
Vertical structure.  The concept Nature of Transitions from Transitions Theory is 
represented by Discharge Transition to HHC in the HHCRM and operationalized as LOS 
and prior readmissions (30 and 90 days). Discharge Transition to HHC, is defined as the 
type, properties and patterns of the transition from hospitalization to home with HHC.  
This representation is useful because it is inclusive of all the properties included in the 
Transitions Theory.  Type, includes Health/Illness and organization.  The Health/Illness 
and Organizational properties are reflected in the discharge transition as the transition 
from hospitalization to recovery at home using the care models within the organization.  
Pattern includes repetition of the transition, which in discharge transition is reflective of 
prior hospitalizations within 30/90 days of the initial admission, which is reported to be a 
characteristic that is high-risk for receiving a HHC referral (Bowles & Cater, 2003; 
Fortinsky, Madigan, Sheehan, Tullai-McGuinness, & Kleppinger, 2014; Mazya et al., 
2013).  Properties are comprised of various properties that are relevant in Discharge 
Transitions to HHC including Change and Difference in the settings of the transition as 
well as the Transition Time span, which is determined by the LOS of the index 
hospitalization (see Figure 2 and Table 1). 
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The concept Transition Conditions:  Facilitators and Inhibitors from Transitions 
Theory is represented by Personal Facilitators and Inhibitors in the HHCRM and is 
operationalized as the patient characteristics considered by the healthcare team to 
determine the need for HHC. Personal Facilitators and Inhibitors are defined as patient 
characteristics that can influence the decision to refer to HHC and can impact post-
discharge outcomes.  Personal Facilitators and Inhibitors include the meanings of the 
transition condition.   Meanings are influences that facilitate or inhibit the transition 
(Meleis et al., 2000).  In the HHCRM, meanings include patient characteristics that help 
determine healthcare team interventions.   The characteristics of interest in the HHCRM 
include: age, functional status, Elixhauser Comorbidity Index (comorbid conditions) 
(“Concept:  Elixhauser Comorbidity Index,” 2016), social support, lives alone, Severity 
of Illness (SOI), and based on statistical modeling either Major Diagnostic Category 
(MDC) or Clinical Classifications Software category (CCS category) (Primary 
Diagnosis) (Agency for Healthcare Research and Quality, 2012). The dimension of 



















decision to refer the patient to HHC and these include: sex, race, and payer (see Figure 3 
and Table 1).  
The concept Patterns of Response from Transitions Theory is represented by post-
discharge utilization in the HHCRM and is operationalized by the post-discharge 
utilization of readmissions and ED visits within 30 and 60 days (2=ED/Obs visit no 
readmission, 1= readmission, 0=no readmission/ED/Obs visit). Mastery is the presence of 
abilities and actions that assist with coping in different situations (Meleis et al., 2000). 
Within the HHCRM, mastery is defined as whether or not the utilization of HHC resulted 
in the increased ability of the patient to remain at home after discharge.  The HHCRM 
will test some health outcomes such as maintenance of baseline functional status and 
increased social support as mediators of the utilization outcome, which is the relationship 
of HHC to post-discharge utilization that were also identified from the literature as 
patient characteristics that are high-risk for referral to HHC.  The absence of post-
discharge utilization is used in this study as an indicator of mastery of the discharge 
transition.  Mastery can be connected with the utilization outcome of post-discharge 
utilization in that the patient discharged to home is able to complete their convalescence 
in the home without an unplanned readmission or ED visit (see Figure 3 and Table 1).    
The concept of Nursing Therapeutics from the Transitions Theory is represented 
by the Healthcare Team Therapeutics: HHC referral in the HHCRM and is 
operationalized by the presence or lack of a HHC referral (1=yes/0=no).  This is a useful 
representation of Nursing Therapeutics as an example of an individualized therapeutic 
intervention provided to patients by the healthcare team to facilitate a positive outcome 





Meleis’ Transitions Theory is a logical conceptual level theory for the HHCRM.  
They are both processes linked to an outcome and are affected by continually changing 
conditions and individual patient experiences.  The framework for Meleis’ Theory of 
Transitions combined with the Home Health Care Referral model enhances the 
researchers’ level of understanding about how patient characteristics and transitional 
experiences impact HHC referral decision making and subsequently post-discharge 
utilization outcomes.   
Statement of Assumptions of the Study 
It is important to determine and disclose the underlying assumptions of a study.  
Disclosing assumptions helps to create an understanding of an author values and beliefs 
(Chinn & Kramer, 2011) and enhanced understanding of the stated concepts.  In this 
study, there were several assumptions including: 
1) Referral is positively associated with receiving HHC 
2) Readmissions and ED/Obs visits are equally accurately documented and 
reflect the true underlying patterns of post-discharge utilization in the 
treatment and comparison groups 
3) Contextual confounding differences (facilitators and inhibitors) between the 
treatment and comparison groups are properly accounted for 
Review of Literature 
A review of the literature in the relationship between HHC and readmissions was 
conducted using the integrative review framework of Whitmore and Knafl (2005).  The 





manuscript titled The Effectiveness of Home Health Care for Reducing Readmissions:  
An Integrative Review (See appendix A). 
Summary of the gaps.  The review of the literature identified two significant 
gaps.  First, few studies investigated the health outcomes of HHC.  Many of the studies 
identified were conducted greater than 10 years ago with limited quality and breadth.  
Second, a methodological gap was identified where current studies measuring HHC 
effectiveness were challenged by insufficient controls and dissimilar 
treatment/comparison groups.  These methodological gaps present an opportunity for 
designing studies with attention to sample selection.   In light of these issues, the 
effectiveness of HHC cannot be determined. This study investigates the effectiveness of 
utilizing HHC to reduce post-discharge utilization while using statistical methods to 
promote comparability of the treatment/comparison groups.   
Summary 
 This chapter provided the philosophical underpinnings of the study with detailed 
information regarding the post-positivist lens which this study, was completed.  The 
HHCRM theoretical framework used in this study, which was derived from Meleis’ 
Transitions Theory, was presented and explained. Assumptions of the study were also 
presented.  The review of the literature on the effectiveness of home health care on 
readmissions was presented as a submitted manuscript and gaps in the literature 






CHAPTER III:  RESEARCH DESIGN  
 
The primary goal of this study was to answer the research question relating to 
Home Health Care’s (HHC) relationship to readmissions and ED/Obs visits while adding 
to the health services research body of knowledge, and advancing the science of nursing.  
The methodology used to test the research question is presented in this chapter.  The 
chapter is organized into sections: 1) description of research design; 2) description of 
methodological procedure; 3) sample derivation; 4) measures; 5) description of statistical 
procedure; 6) human subject protection; and 7) limitations.  
Description of Research Design  
The purpose of this research study was to determine, and subsequently inform the 
healthcare community and its consumers, on the effectiveness of referral to Home Health 
Care in reducing post-discharge utilization by comparing patients with similar 
characteristics who are discharged to home with and without referral to home health 
services.  
The following aim guided the design of the study.  
Aim:  To determine the effectiveness of HHC in reducing return to hospital after 
discharge  
Research Question (RQ):  What patient characteristics are associated with the 
initiation of a referral for HHC prior to hospital discharge?  The matched sample used to 





the initiation of a referral for HHC as ascertained from RQ1and accessible in the existing 
(READI study) database. 
Hypothesis: When comparing patients referred to HHC with a comparable group of 
patients with the same characteristics not referred to HHC, patients who receive a referral 
will have fewer occurrences of post-discharge utilization occurrences within 30 days and 
between 31 and 60 days after hospital discharge. 
 This study used a comparative design with matched samples involving the 
secondary analysis of data derived from the parent study “Readiness Evaluation And 
Discharge Interventions (READI)”.   The READI study is a 34 hospital multi-site study 
of unit-level implementation of a standard protocol for discharge readiness assessment 
(treatment) on readmissions and ED visits post-discharge (utilization outcome).   The 
READI study evaluated 3 protocols for implementing discharge readiness assessment 
using a study design that included patients from randomly assigned implementation and 
control units. This study used comparative design with equivalent treatment and control 
comparison groups (referred versus not-referred to HHC for post-discharge care). The 
groups compared included patients with similar characteristics who have received a HHC 
referral and those patients not receiving a referral. 
Effectiveness studies are often used in a health services context to explore the 
value of treatments and treatment outcomes under care and practices (Wells, 1999).  
Despite usefulness in examining long term outcomes, effectiveness studies are prone to 
have problems with external validity due to sampling methods (Wells, 1999).  Validity 





but more importantly, the chance of a type I (false positive) error (Lachin, 2000).  This is 
a risk that requires specific attention to mitigate.   Selection bias was addressed to help 
establish an unbiased study.  All identified sample patients were randomly selected and 
included in the analysis.  This is important for the follow-up and evaluation of the 
outcome (post-discharge utilization).  The post-discharge utilization outcome was 
evaluated for both groups of patients (referral/no referral) in the same manner.  If, during 
the evaluation of utilization outcomes, a missing post-discharge outcome value was 
identified, it was excluded. 
Strategies to manage the challenges associated with cluster-level data were 
deployed.  The challenge was that all participants within the cluster have individual 
attributes that may not be readily detected. Unobserved characteristics introduce the 
possibility of a decrease in accuracy of the predictions (Green & Vavreck, 2008).  This 
study utilized a cluster comprised of multiple hospitals.  To address this issue, sample 
patients of the treatment (referral/no referral) group were randomly selected to attempt to 
generate an unbiased estimate of the treatment.  For example, each hospital was given its 
own identifier that was used as one of the variables in matching analyses.  This approach 
assumed that all hospitals generally possess similar characteristics.  
Intent-to-treat studies are used to evaluate new treatment(s) and effectiveness of 
the treatment is determined by comparing the outcome of groups (Lachin, 2000).  This 
was an intent-to-treat study where all participants were randomized and observed through 
to the outcome of interest, which in this study, was the utilization outcome of post-
discharge utilization. However, it was not designed to initially randomize its treatment for 





been described by at least one author as an “as-treated” study (Wells, 1999).  The concern 
with an as-treated study, is that the characteristics of the individual receiving or not 
receiving the treatment (referral) may differ and cause bias in the estimates of treatment 
effects (Wells, 1999).  This risk of bias was mitigated with the use matching 
methodologies (exact and Mahalanobis distance matching) that was performed to create 
equal groups thereby addressing the differences existing in the as-treated group.   
 
Figure 3:  Research question model 
Description of Methodological Procedure 
Data source.  The source of data for this study was patient data already recorded 
in the READI study dataset. The dataset includes more than 140,000 de-identified patient 
encounters from 34 Magnet-designated hospitals in the U.S. and Saudi Arabia. Eligibility 
criteria for the READI study include patients from each hospital whose hospital stay 
occurred on designated study units at each hospital that were randomly assigned as an 





been at least 18 years old, and were discharged to their homes either with or without 
Home Health Care (“READI,” 2017). Data for the READI study contains data primarily 
collected directly from patients using the Patient Readiness for Discharge Survey 
(PTRHDS), and nurses, who as part of the READI protocol to assess readiness, recorded 
items on the READI nurse assessment form from nurse knowledge or patient self-report, 
and data extracted from Electronic Health Records (EHR).  Data extraction from 
Electronic Health Records has been found to be a reliable tool with a 95.5% agreement 
with paper records (Masoe, Blinkhorn, Colyvas, Taylor, & Blinkhorn, 2015) and is 
identified as the gold standard for obtaining outcome information (Cox et al., 2009). The 
dataset includes patient disposition at discharge, indicating whether a home health 
referral had been made, as well as patient characteristics relevant to the study aim, and 
indicators for readmissions and ED visits within 30 and between 31 and 60 days.  
Sample derivation.  In this study, it was essential that efforts are made to create 
samples that were as closely matched as possible to establish comparable groups.  To 
achieve comparable groups, predictive analyses, such as logistic regression, were 
completed through the research question and followed by matching methodologies in the 
hypothesis. 
For the research question, sample inclusion criteria included all patient encounters 
from 29 US hospitals (excluding one US hospital with incomplete data and two Saudi 
Arabian hospitals as well as 2 hospitals not reporting HHC referrals) within the READI 
study.  This sample included members of the control units from all four phases of the 
study including the baseline time period and discharged to home either with or without a 





patient characteristics without the risk of being confounded by the intervention(s) of the 
implementation units. Exclusion criteria included members from all phases of the 
implementation units of the READI study.  Studying this sample allowed us to determine 
prominent patient characteristics that differentiate the initiation of a HHC referral prior to 
discharge.  
A second sample was created for the hypothesis.  The inclusion criteria for the 
sample were all patient encounters from 29 US hospitals (excluding one US hospital with 
incomplete data and two Saudi Arabian hospitals as well as 2 hospitals that did not report 
HHC referral data) included in the READI study database who were members of the 
designated implementation units at the time of hospital admission, participated in phases 
2 and 3 of the study, and were discharged home with or without a referral to HHC.  The 
decision was made to limit data collection to phases 2 and 3 of the READI study because 
these phases included patient self-report measures of patient characteristics of interest to 
the study, reported on the PTRHDS. The exclusion criteria for this group were members 
of the control units and members in phase 1 of the implementation units of the READI 
study. 
 The sample for the hypothesis was divided into 2 groups (those with a HHC 
referral and those without).  The treatment group included a sampling of READI study 
patients who were referred to HHC.  The patients were grouped through matching 
methodologies including exact matching and Mahalanobis distance matching using 
variables of interest and/or variables informed by the research question.  The groups were 





patient referred to HHC. A detailed description of the matching procedures can be found 
on page 50. 
This study used statistical methodology such as exact matching and Mahalanobis 
distance matching to mitigate the impact of varying patient characteristics between the 
groups. These methodologies use study variables to create the closest comparison groups 
possible to determine the effectiveness of the HHC referral in reducing post-discharge 
utilization.  Relevant research indicates that the best performing readmission predictive 
models include comorbidities, prior healthcare utilization, and functional status 
(Kansagara et al., 2011).  Based on variables available in the database for this study, the 
variables used for exact matching included sex, race, ethnicity, prior hospitalization 
within the past 90 days, nurse-reported functional status, lives alone, medical/surgical 
patient type, hospital unit, quartile length of stay, and above or below median Elixhauser 
comorbidity Index score as was determined during statistical modeling.  Following exact 
matching, matches were further refined by using Mahalanobis metric distance matching 
from select patient characteristics identified as predictive of HHC referral in Research 
Question of this study.  Preliminarily, the important variables were age, patient-reported 
functional status, social support and propensity score (to adjust for the likelihood of HHC 
referral), with final variables were informed by the research question.   
Sample size. For the research question, the sample size included the entire sample 
of the control group.  Estimates indicated a sample size of approximately 58,580 patient 
encounters discharged to home with HHC available in the READI study.  The purpose of 
using the control group of patients was to use the propensity score to balance the risk of 





not confounded by any phase of the intervention.  For the hypothesis, where sample size 
is drawn from phases 2 and 3 of the READI study, there was an estimated sample size of 
size of approximately 18,774. 
Measures 
Research Question Variables 
Independent variable.  Independent variables in the research question were the 
patient characteristics, which were used as predictors of whether or not patients receive a 
HHC referral on the day of discharge. 
Patient characteristics  The independent variables for the research question were 
those patient characteristics identified during the review of the literature indicating high-
risk for HHC referral.  These variables may include LOS, age, sex, race, payer , 
functional status, Elixhauser Comorbidity Index (“Concept: Elixhauser Comorbidity 
Index,” 2016), social support, lives alone, complex needs (SOI as proxy), MDC (Agency 
for Healthcare Research and Quality, 2012), and hospital.  The data for the patient 
characteristic variables was obtained from various sources including the Electronic 
Health Record (EHR) [LOS, age, Elixhauser Index (“Concept: Elixhauser Comorbidity 
Index,” 2016), demographics (sex and race), SOI (using APR-DRG codes), and payer 
(type of insurance coverage the patient has)] (See Table 1). 
Variables from electronic health record.  The variables collected using the 
EHR included 1) Length of Stay [LOS; identified as the number of hospital days 





including the day of discharge] (Bowles et al., 2003; Holland & Bowles, 2012; Naylor et 
al., 2012); 2) age [age of the patient in years] (Leppin et al., 2014; Murtaugh et al., 2016);  
3) presence of comorbid conditions using the Elixhauser Comorbidity Index [score will 
be used as a proxy for severity of comorbidities] (Thompson et al., 2015);  4) presence of 
complex patient needs including data from the Severity of Illness Index from the APR-
DRG coding scheme [used as a proxy for complexity of care needs] (Coleman, 2003; 
Leppin et al., 2015; Low et al., 2015); 5) type of insurance using payer of record (Leppin 
et al., 2014);  6) certain demographics including race and sex (Leppin et al., 2015; Low et 
al., 2015; Wong et al., 2015); and 7) MDC using ICD-9 and ICD-10 scores [used as a 
proxy for primary diagnosis] (See Table 1).  
Research Question Dependent Variables 
Referral to home health care.  The referral to HHC variable was dichotomous, 
indicating whether or not a referral was made before the patients' discharge from the 
hospital.  The data for this variable was provided by the discharge disposition code coded 
in the EHR.  The variable was coded as 1=yes; a referral was made, and 0=no; referral 
was not made. There is limited information regarding the actual receipt of HHC services 
from the referral. The READI dataset does indicate when a patient has been 
discharged/transferred to home under the care of a HHC organization (coded with the 
single digit 6) representing the intent to treat with HHC.  However, no information is 
available detailing previous HHC use, whether or not HHC actually occurred, how often 
HHC visits occurred, or other types of service occurred (See Table 1).  





Hospital unit.  For this study, hospital was defined as the organization that the 
patient was admitted to for care and treatment.   The hospital was identified using a 
number in place of the organization title.  These data represented unmeasured 
organizational characteristics (See Table 1). 
Hypothesis Variables 
 Independent variable.  For the hypothesis, referral to HHC, the dependent 
variable in the research question became the independent variable in this analysis.  This 
independent variable was whether or not a referral was made before the patients' 
discharge from the hospital.  This was a dichotomous variable measured as 1=yes 
(referral received) and 0=no (no referral received).   
dependent variable.  The dependent variable in the hypothesis is the post 
discharge utilization of services (30 days and 60 days).  The utilization outcome measure 
for this study were 30-day and 60-day same-hospital all cause readmissions and/or 
ED/Observation (ED/Obs) visits.  The dependent multinomial variable was post-
discharge utilization coded as 0= no readmission or ED/Obs, 1= readmission, and 2= 
ED/Obs visit without a readmission.  The 30-day readmission rate was defined as one or 
more return visits to the hospital that included an inpatient stay either with or without an 
ED/Obs visit (1=yes, 0=no) within 30 days after discharge from the index hospital stay.  
An ED/Obs visits were combined and defined as one or more visits to the ED/Obs 
without an inpatient admission (1=yes, 0=no).  Furthermore, Observation visits included 
visits to the ED that did not result in an inpatient admission, but may have included a 





hospital discharge between 31 and 60 days after the index hospital discharge. These data 
were provided by the hospital and were dichotomous variables answered as yes/no 
(1=yes, 0=no).  The 60-day ED/Obs visit was defined as a return to the ED after hospital 
discharge that did not result in admission to the hospital between 31 and 60 days.   The 
30 day and 60-day readmission and ED/Obs visit time frames are usual time intervals 
reported in health services research and were selected to clarify each variable and keep 
readmission data distinct and mutually exclusive (See Table 1).  
Hypothesis Exact Match Variables 
Hospital unit.  The organization that the patient was admitted to and from which 
they received their care and treatment. The hospital was identified using a number in 
place of the organization title.  These data represented unmeasured organizational 
characteristics (See Table 1). 
Functional ability.  One READI nurse assessment form question conducted on 
the day of discharge was used as a data source for patient characteristics (“READI,” 
2017).  The first question was used to determine functional ability and is recorded by the 
RN as a dichotomous response of independent or not independent (See Table 1). 
Patient characteristics.  The variables collected using the EHR included: 1) 
demographic information including a) sex (Leppin et al., 2014; Low et al., 2015; Wong et 
al., 2015); b) race (unknown, Native American/Alaskan, Asian American, Black/African 
American, Hawaiian/Pacific Islander, White), and c) ethnicity (Hispanic, Non-Hispanic, 
unknown) and 2) the MDC using ICD 9 and ICD 10 scores [used as a proxy for primary 





[LOS; identified as the number of hospital days calculated by the number of midnights 
between the day after admission up to and including the day of discharge and matched by 
quartiles] (Bowles et al., 2003; Holland & Bowles, 2012; Mary D Naylor et al., 2012); 3) 
medical/surgical patient type and, 5) lives alone [identified from the READI nurse 
assessment form by the RN as a dichotomous response of yes/no] and 6) presence of 
comorbid conditions using the Elixhauser Comorbidity Index [score will be used as a 
proxy for severity of comorbidities] (Thompson et al., 2015);  . 
Hypothesis Mahalanobis Distance Matching Variables 
Patient characteristics.  The variables collected using the EHR included: 1) age 
(age of the patient in years) (Leppin et al., 2014; Murtaugh et al., 2016) 
Functional status.  This study used one single-item question from the PTRHDS 
short form instrument used in the parent study. The continuous range single item question 
used in this study helped identify a patient’s functional status and the amount of help a 
patient anticipated with their personal and medical care at home.  The question included 
“How well will you be able to perform your personal care (for example, hygiene, bathing, 
toileting, eating) at home?”  This question was selected from the instrument because of 
the consistency to which it correlated to the patient characteristic identified in the 
literature (Bowles et al., 2010; Bowles & Cater, 2003; Bowles et al., 2002; Holland & 
Bowles, 2012; Murtaugh et al., 2016; Naylor et al., 2011; Wong et al., 2015) of  
functional ability (Bowles et al., 2008; Holland & Bowles, 2012; Leppin et al., 2014).  
Propensity score.  The estimated propensity score for HHC referral was 





score was used as a variable during Mahalanobis distance matching to determine the 
overall likelihood of post-discharge utilization (See Table 1).  Variables included in the 
propensity score include 1) LOS, 2) age, 3) Severity of Illness (SOI), 4) DRG, 5) payer, 
6) race, 7) ethnicity, 8) MDC, 9) Patient diagnosis type (medical/surgical), 10) prior 
hospitalization (30day and 31-90 day), 11) ICU days, 12) Elixhauser Comorbidity Index, 
13) race/ethnicity interactions, and 14) hospital fixed effects.   See the Description of 
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Description of Statistical Procedures 
Analyses for this study were conducted by Drs. Olga Yakusheva and James Bang. 
The analysis plan was developed in consultation with Drs. Yakusheva and James Bang. 
Ongoing consultation occurred throughout the analysis process and as needed.  
Data were examined for missing values.  Missing variables will be managed 
differently based on the information missing.  For missing values in the PTRHDS, the 
scores will be imputed from other responses of the patient (minimum of 2-3 present).  
Missing data were dropped in the analyses for variables where imputation is not possible 
such as age, and length of stay (LOS).  Cases were dropped when a missing utilization 
outcome variable (Readmission or ED visit within 30 and 60 days) was identified.   
Research question.  For the research question, the lists of potential covariates 
were selected from patient characteristics identified in the review of literature for factors 
associated with HHC referral and readmission.  The patient characteristics of interest 
include: prior hospitalization within 90 days, ICU days, LOS, Elixhauser Comorbidity 
Index, complex needs (using a proxy of SOI), payer, medical/surgical patient type, age, 
gender, race, ethnicity and their interactions, MDC, and hospital code.  This initial 
sample of patients was analyzed to identify the distinguishing patient characteristics that 
are most predictive of a referral to HHC following discharge. The patient characteristics 
served as covariates in the study and subsequent statistical analysis. 
The statistical procedures used in the research question included logistic 
regression.  Logistic regression is used to predict belonging to a specific group (Warner, 




those characteristics that are most closely associated with the initiation of a HHC referral. 
The completed analysis provided estimated propensity scores that were used as a control 
variable to achieve a closer match of patients predicting the likelihood of receiving a 
HHC referral.  
 The purpose of propensity scoring is to estimate the probability of a participant to 
receive treatment based on certain covariates. The propensity score helps to explain the 
odds of receiving treatment (Guo & Fraser, 2015).  The resulting score, is the balancing 
score of the path of covariates (Guo & Fraser, 2015). The result is the estimated score 
(between 0-1) and reinforces the inclusion of the covariate into the analysis.  Caution 
must be taken to carefully identify the relationships of the covariates to minimize the 
influence of unwanted or unobserved covariates included in calculation of the propensity 
score (Pan & Bai, 2016). Sensitivity testing on the propensity score model is 
recommended in an attempt to identify unknown covariates (Rosenbaum & Rubin, 1983).  
The hypothesis utilized a second sample of patients.  
Generating the matched sample.  The analysis for the hypothesis required a 
matched treatment/comparison sample, which included the entire eligible sample.  The 
match ratio was a 1: 1 match. Two matching methodologies were used to generate the 
matched sample (exact matching and Mahalanobis distance matching). Since two 
methods of matching were used, criteria were created to determine optimal matching 
methods for each variable.  Criteria included 1) importance of the variable to post-
discharge utilization (functional status to readmission), 2) ability to make the closest/best 




example, based on the literature, age was a more prominent variable than payer in 
readmission prediction and with the chance of collinearity with payer, we chose to 
distance match age and include payer in the propensity score. Using these criteria, two 
methods of exact and Mahalanobis distance matching were used to create comparable 
HHC referral and no HHC referral groups. 
The first method of matching used was exact matching.  Exact matching is a form 
of Mahalanobis distance matching where an exact match between a HHC referral patient 
and a non-HHC referral patient is required. The variables that used for exact matching 
included gender, race, ethnicity, prior hospitalization within 90 days, nurse-reported 
functional status, lives alone, medical/surgical patient type, LOS (quartiles), and mean 
Elixhauser comorbidity index.  Mahalanobis Distance Matching will be used to continue 
matching patients on additional characteristics (age, patient-reported functional ability, 
social support, and propensity score). 
The first step of Mahalanobis metric distance matching is to calculate the distance 
between the first treated patient and the control patients (Guo & Fraser, 2015).  The 
resulting distance is called the Mahalanobis metric distance. The closest Mahalanobis 
metric distance between the referral participant and the non-referral participant are 
considered a match and both are removed from the sample and further matching (Guo & 
Fraser, 2015). This process continued until all treated participants are matched. 
Mahalanobis distance matching variables for this study included age, patient reported 
functional ability, social support, and propensity score (likelihood of HHC assignment).  
However, as each covariate is introduced the expected Mahalanobis metric distance will 




addition of the estimated propensity score as a matching variable assisted by more closely 
matching the referral and non-referral groups despite a lengthening Mahalanobis metric 
distance.  
 The goal of Mahalanobis distance matching is to assess the effects of a treatment 
while controlling for non-random assignment to treatment/comparison groups.  This 
method of analysis is appropriate to use when a) randomized control trials are not 
feasible, or b) when data is collected by observation of systems under usual practice and 
without interventions implemented by randomized assignment rules (Guo & Fraser, 
2015), both which apply to this study.  However, as with any statistical analysis, pitfalls 
do exist.  Some pitfalls that exist within matching analysis include inadequate 
specification of the propensity score model (Austin, 2011) and threats to internal validity 
(Guo & Fraser, 2015) such as selection bias or confounding that may impact the 
evaluation of the outcome. There is an opportunity for selection bias if covariates are 
neither well vetted nor applicable to both the treatment and the control groups (Pan & 
Bai, 2016).  Mitigation of this bias has occurred as a result of a thorough review where all 
selected covariates were identified within the literature. Also, a large sample size is 
recommended for covariate balancing (Austin, 2011).  The use of a large sample size will 
provide a broader base of covariates to match and score (Pan & Bai, 2016) and is 
applicable to this study. Exact matching and Mahalanobis Distance Matching are 
accepted statistical methodologies that assist in pairing patients with similar 
characteristics to adequately measure the existence of a relationship of HHC to 
readmissions while controlling for as many covariates as possible and correcting for 




 The decision to use two types of matching was made as a result of the challenges 
identified within the literature review.  The most significant challenge being the lack of 
comparable groups for patients receiving HHC referrals.  Currently, the sickest and most 
high-risk patients are referred for HHC (Bowles et al., 2008); these patients are the most 
likely to experience post-discharge utilization.  Without a comparison group of patients 
with similar characteristics who did not receive a HHC referral, the utility of HHC to 
reduce readmissions cannot be adequately measured. 
Analysis of the hypothesis. Once the sample was generated, to test the 
hypothesis, the relationship of HHC with readmissions and ED visits were explored using 
a two-sample test of proportion with a 2x3 (HHC [yes/no] x readmission/ED/Obs/no 
giving a preliminary estimate unadjusted for any control variables. An adjusted 
multinomial logit regression model was calculated using variables with significant 
differences between HHC and non-HHC as controls.  Then, two logit regression models, 
one for readmissions within 30 days (yes/no) and one for readmissions within 60 days 
(yes/no) were performed. A logit model was selected to test the hypothesis because 1) the 
dependent variable, post-discharge return to hospital, is categorical with 3 possible 
outcomes, and 2) the resulting coefficient helps to interpret the expected impact a one 
unit change in the predictor variables (post-discharge return to hospital) would have on 
the dependent variable (post-discharge return to hospital) while all other variables remain 
the same.   




This study was a secondary data analysis of a multi-site study with an existing de-
identified data set already approved through Marquette University IRB as well as the 
individual hospital IRBs, and received IRB exempt status approval. All data for this study 
was obtained from the READI database and were previously de-identified before entering 
the parent study database. All variables for this study were extracted from electronic 
systems and through RN and patient data forms.  Data from multiple files of the parent 
study, including patient characteristics were merged to create a single dataset.  All data 
obtained has been stored in an encrypted, password-protected data cloud protecting all 
available information.  It is accessible to the PI, the PI’s advisor, and the statistical 
analysts of record for the parent study who assisted with data retrieval and analysis.   
Limitations 
 There were several limitations identified in this study.  Some of the limitations 
were a result of the dataset used, and others are inherent in the study design.  Despite 
efforts for a complete dataset, there is some information in hospital data extracts that was 
not available in the parent study database.  Data not collected in the parent study and 
therefore not available for this analysis includes some of the patient characteristics 
identified as high risk for readmission such as self-reported rating of current health (fair, 
low, very low).  Previous HHC referral/use and post-referral HHC information was also 
not included from the database. Also unavailable are details regarding the content of the 
HHC visit(s), the quality of the care provided by the individual home health nurse and/or 
HHC agency, and/or the health outcome of the visit, thereby making this an intent to treat 




  The introduction of bias, overt or hidden, is a threat frequently seen in 
observational studies (Guo & Fraser, 2015). When using an existing database for 
secondary analysis, it is essential that the study includes a well specified model to limit 
bias within the study. A well specified model requires that the analysis include all 
variables applicable to the topic of interest and does not include those variables that are 
not applicable (Warner, 2013).  A poorly specified model can introduce specification bias 
into the study and affect the variance of the analysis (Rao, 1971). An incorrectly specified 
model is a threat to the internal validity through hidden bias of the data and is a potential 
limitation to the study.  Since certain patient characteristics and post-referral information 
were not collected in the parent dataset such as refusal of HHC services, the number of 
HHC visits ordered and completed, and activities completed during the HHC visit, there 
is a considerable risk of hidden bias in this study and is a potential limitation of the study. 
 Readmissions have been defined as hospital admissions within 30 and 60 days as 
well as the occurrence of one or more visits to the ED.  However, the recognition of a 
readmission event can only be made when the readmission occurs at the same ED or 
hospital of the admission of interest admission. Unless EHR technology is leveraged 
where outside occurrences of hospital admissions and ED visits can be viewed, these 
episodes of care remain unknown to the organization currently providing care. The 
estimated average difference between same-hospital reporting and all-hospital reporting 
is estimated to range between 1% and 5% (Nasir et al., 2010).  Tracking outside 
readmissions is challenging and is demanding of both human and financial resources 




hospital admissions and ED visits.  This gap exists within the study dataset and creates an 
additional limitation to the study.  
Summary 
This chapter restated the purpose of this research and presented the research 
questions. Study participants were randomly chosen from 31 U.S. hospitals within the 
READI dataset. This study discussed the study aim in conjunction with initial samples 
used for each research question as well as statistical analysis procedures, human rights 
protections, and study limitations.   
 57
CHAPTER IV:  METHODS 
 
To determine the HHC effect on post-discharge return to hospital, matched 
samples of patients referred and not referred to HHC were examined. This chapter 
represents the results of the data analysis for the stated research questions.   
 The results of the data analysis are included in the manuscript titled The Home 






CHAPTER V:  RESULTS 
 
This chapter includes a discussion of the findings, implications for practice, 
recommendations for further research, and conclusions.  The chapter will end with the 
implications of the findings on vulnerable populations.   
 The discussion, implications for practice, recommendations for future research, 
and conclusions are included in the manuscript titled The Home Health Care Effect on 
Post-Discharge Return to Hospital (Appendix B). 
Implications of Study Findings on Vulnerable Populations 
 This study’s findings indicated that HHC may not be effective at reducing 
readmissions and ED/Obs visits, having a considerable impact on vulnerable populations 
such as the sick and the elderly. Evidence suggests that spending associated with sick and 
elderly individuals is related to patients requiring care to help manage uncontrolled 
conditions (Naylor et al., 2012), which HHC is well positioned to impact because it 
aligns with HHC’s expertise as specialists in treating patients with prior hospitalizations 
from acute illness and management of chronic conditions in the community (Alliance for 
Home Health Quality and Innovation, 2014).  As the focus on early rehospitalizations 
continues, it is important that healthcare professionals understand the level of 
effectiveness of the treatments both prescribed and provided.  Home Health Care has 
been described as the most commonly used post-hospitalization bridge strategy (Bowles 
et al., 2009) to prevent readmissions, but based on the results of this study, readmission 





organizations and their providers to enhance readmission avoidance efforts and protect 
their most vulnerable and resource intensive patients from early readmissions and 
ED/Obs visits.  In the HHC post-acute care setting, the opportunity exists to advance 
national priorities on readmission prevention as a priority of HHC while increasing their 
improvement efforts, through process and outcome measurement, in order to achieve a 
goal of reduced readmissions and ED/Obs visits.    
 Home Health Care improvement opportunities exist across all groups of patients 
including 30 and 60-day readmissions and ED/Obs visits and in both low and high-
comorbidity patients.  Strategic planning efforts and specialty programs designed to 
provide decision support tools and just-in-time medical treatment to HHC patients can 
help HHC agencies and nurses with proactive outcome management.  
 The findings of this study present HHC providers with insight to the effectiveness 
of their care particularly with the sick and the elderly.  With an increased risk of 
morbidity and mortality, the needs of these vulnerable populations are linked with health 
resource utilization and outcomes (Shi & Stevens, 2010).  Tailored interventions by HHC 
agencies to improve both readmissions and ED/Obs visits for the most vulnerable 
community-dwelling patients will assist in reducing healthcare disparities associated with 
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Background: Home Health Care (HHC), a commonly used bridge strategy for 
transitioning from hospital to home-based care, is expected to contribute to 
readmission avoidance efforts.  However, in studies using disease-specific 
samples, evidence about the effectiveness of HHC in reducing readmissions is 
mixed.  
Objective: To examine the effectiveness of HHC in reducing post-discharge 
utilization across a diverse sample of patients discharged home following acute 
care hospitalization. 
Research Design: Comparison of matched samples of HHC and non-HHC 
patients; secondary analysis of a multi-site dataset from a study of discharge 
readiness assessment and post-discharge return to hospital.  
Subjects: The available sample (n=18,744) included patients referred 
(n=3,629) and not referred (n=15,145) to HHC. The matched sample included 
2,718 pairs of HHC and non-HHC patients matched on patient and hospitalization 
characteristics using exact and Mahalanobis distance matching.  
Measure: Readmissions and Emergency Department [ED]/Observation visits 
within 30 and 60-days post-discharge.   
Results:  Using unadjusted t-tests and adjusted multinomial logit regression 
analyses, no statistically significant differences in readmissions or 





for HHC-referred low-comorbidity patients who had 2.2 percentage points higher 
30-day ED/Observation visit rates.   
Conclusions:   HHC and non-HHC patients matched on patient and clinical 
condition characteristics have similar rates of return to hospital within 30 and 60 
days.  This result raises the question of why HHC services did not produce 
evidence of lower post-discharge return to hospital rates. Focused attention by 
HHC programs on strategies to reduce readmissions is needed.   
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As a critical component of the continuum of care from hospitalization to post-
hospitalization, Home Health Care (HHC) serves as the most common bridge strategy (1) 
used to reduce length of stay (LOS) and cost of hospital care. Reducing preventable 
readmissions, a goal of HHC agencies and quality improvement organizations (2, 3),  can 
influence health system performance reporting and reimbursement. Implemented in 2012, 
the Hospital Readmissions Reduction Program (HRRP) tied reimbursement to publicly 
reported goals, including hospital readmission reductions (4).  As a result, hospitals 
forged relationships with HHC agencies to assist with readmission reduction efforts (5). 
 Other federal initiatives affect readmissions either through quality reporting or 
through payment reform.  In 2014, the Improving Medicare Post-Acute Care 
Transformation (IMPACT) Act was passed. Among other things, the law modified 
Outcome and Assessment Information Set (OASIS) reporting requirements to standardize 
data across other post-acute settings and created new measures, including potentially 
preventable readmission (6). Health care systems participating in Accountable Care 
Organizations (ACOs) or Bundled Payments for Care Improvement (BPCI) models may 
rely on less costly HHC to reduce readmissions and lower costs (7). Both of these models 
are designed to improve efficiency, quality, and coordination of care during the post-
discharge transition and across the care continuum (8, 9).  
Reports of the effectiveness of HHC in reducing readmissions are mixed. Many 
studies report higher rates of readmission for patients receiving HHC than patients 
without HHC services post-discharge (10-13).   For example, rates of readmission post-





(HHC= 24.3% vs non-HHC=19.8% within 30 days) (13),  abdominal surgery 
(HHC=62% vs. non-HHC=11% within 30 days) (11), joint replacement (HHC=10.5% vs 
non-HHC=5.1% within 6 months) (10), and  community acquired pneumonia patients 
(HHC= 20.1% vs non-HHC= 11.5% within 30 days) (12).   Other studies of Congestive 
Heart Failure (CHF) patients find that HHC reduces readmissions over non-HHC usual 
care.  For example, a paired comparison of CHF patients before and after implementation 
of a HHC program found a mean decrease in the post-implementation group readmissions 
of 2.8 hospitalizations per month (14). In a meta-analysis of transitional care 
interventions and readmissions in Congestive Heart Failure (CHF) patients (15), only two 
of forty-seven were randomized controlled trials of a home visiting intervention with 
readmission measured within 30-days post-hospital discharge; one of the studies reported 
a reduction in readmissions (16) for patients receiving home visiting. Several other 
studies reported effectiveness of home visiting at three and 6 months (15).    
In contrast to the extant literature, our study matches HHC and non-HHC groups 
from a more broadly defined population of patients discharged from acute care hospitals, 
rather than particular conditions. The purpose of this study is to estimate the overall 
effectiveness of HHC in avoiding post-discharge return to the hospital for readmission or 
Emergency Department (ED)/Observation (Obs) visits.  
Theoretical Framework 
Meleis’ Transition Theory (17) provided the framework used to guide the design 
and selection of variables included in this study (see Figure: Supplemental Digital 
Content: Effectiveness of HHC, Figure 1). The notion that HHC is a bridge strategy to 





variables are the factors related to the hospitalization (prior hospitalization and LOS) that 
can affect the “pattern of response” to the transition (readmission or ED/Obs visits).  
“Transition conditions” are the personal characteristics that facilitate or inhibit successful 
transition (e.g., age, sex, and payer).  “Therapeutics” includes actions of the health team 
to influence the transition and is represented in this study by the decision to refer to HHC 
(Supplemental Digital Content:  Effectiveness of HHC: Figure 1, Conceptual Model).  
METHODS 
Using a matched sample comparative design, this study was a secondary analysis 
of a multi-site randomized clinical trial evaluating the effectiveness of standardized 
discharge readiness protocols in reducing post-discharge readmissions and ED/Obs visits 
through 30 and 60-days. The parent study was conducted on 2 adult medical-surgical 
units in each of 33 Magnet hospitals in the United States (US) (31 hospitals) and Saudi 
Arabia (2 hospitals), which were randomly assigned to implementation and control 
conditions.  The study accrued a total sample of 144,868 inpatients discharged to home.   
Sample 
The sample for this analysis included adults (18+ years), admitted to the hospital 
as an inpatient and subsequently discharged to home from an adult medical-surgical unit 
with or without referral to HHC.  Patients from non-US hospitals and from 2 hospitals not 
reporting HHC referrals were excluded.  The sample was further restricted to patients 
from implementation units and two of four phases of the parent study where nurse 
assessments and patient self-reports of discharge readiness were included in the study 





(functional status, lives alone, independence, and expected amount of social support after 
discharge) obtained directly from patients and nurses only in these implementation 
phases.  
The available sample (full sample n=18,744) included patients referred to HHC 
(n=3,629) and not referred (n= 15,145) to HHC.  In order to compare patients with 
similar observable characteristics in the analytic sample, we 1:1 matched each patient 
with an HHC referral to one without an HHC referral using both exact and Mahalanobis 
distance matching techniques. Out of 3,629 patients referred to HHC, 2,718 were 
matched successfully (matched HHC patients) to 2,718 non-HHC referred patients 
(matched non-HHC).  
Study Variables  
Data were electronically extracted by participating hospitals from their health 
information systems and de-identified data were supplied to the parent study database. 
HHC referral prior to discharge (0 = no referral/1 = referral) was derived from the 
hospital discharge disposition code. 
The multinomial outcome variable was post-discharge return to hospital within 30 
and 60 days, coded as: 0=No readmissions or ED/Observation [ED/Obs] visits; 
1=Readmission: defined as the occurrence of one or more return visits to the hospital that 
included an inpatient stay with or without an ED/Obs visit, and 2=ED/Obs: defined as the 
occurrence of one or more visits to the ED or an Observation visit without an inpatient 





not result in an inpatient admission but are assigned a hospital bed (commonly coded as 
short stay <23 hours; outpatient-in-bed).   
Patient characteristic variables were identified based on a review of the literature 
as predictors of HHC referral (19).  These variables included LOS (defined as the number 
of midnights in hospital, categorized in quartiles), age (in years), severity of illness 
([SOI]; major, extreme, moderate, minor [reference], missing) from Diagnostic Related 
Groups (DRG) coding, payer (Medicare, Medicaid, uninsured, private 
insurance[reference], other pay type, and missing), race (unknown, Native 
American/Alaskan, Asian American, Black/African American, Hawaiian/Pacific Islander, 
White[reference]), ethnicity (Hispanic, Non-Hispanic [reference], unknown), sex (female, 
male [reference]), Major Diagnostic Category (MDC) from DRG coding, patient 
diagnosis type (medical/surgical), prior hospitalizations (an inpatient discharge within 30 
days and 31-90 days prior to index admission), ICU days, Elixhauser Comorbidity Index 
(20), race/ethnicity interactions, and hospital code.  
In addition to patient characteristics, nurse-reported and patient-reported variables 
were used for analysis.  Nurse-reported variables included the patient’s functional status 
(0=not independent/ 1=independent) and whether the patient lived alone (0= no/1= yes).  
Patient-reported variables included their self-care ability (0-10 scale) (“How well will 
you be able to perform your personal care (for example hygiene, bathing, toileting, and 
eating) at home”), and social support (0-10 scale) (“How much help will you have with 





A propensity score for referral to HHC was calculated for each patient using a 
propensity score model derived using a separate sample of control group patients from 
the larger parent study (Supplemental Digital Content: Effectiveness of HHC, Methods). 
Data Analysis 
To create the matched samples, we used a combination of exact and Mahalanobis 
distance matching methods to create balanced treatment and non-treatment groups.  We 
selected variables for exact (21) and Mahalanobis Distance matching (21-23) based on 
characteristics identified as significant and clinically meaningful predictors of HHC 
referral from a sample of control group patients from the parent study (Supplemental 
Digital Content: Effectiveness of HHC; Methods, Table 1) as well as patient 
characteristics identified from the literature as indicative of receiving an HHC referral.  
Exact match variables include sex, race, ethnicity, prior hospitalization in the past 90 
days; nurse-reported functional status, lives alone, medical/surgical patient type, hospital 
unit, quartile of length-of-stay, and above or below the median Elixhauser Comorbidity 
Index score.  Mahalanobis distance matching variables include age, patient-reported 
functional status and social support, and propensity score for HHC referral.  
We tested the hypothesis that there would be a reduction in readmissions and 
ED/Obs visits with HHC compared to non-HHC using a two-sample test of proportions.   
As a sensitivity analysis, we calculated a multinomial logit regression to adjust for 
residual differences after distance matching and for MDC.   
All statistical analyses were completed using Stata version 14 (24) with a  p <.05 






The rate of referral to HHC prior to discharge was 19.3% (N=3,629) for the 
available (full) sample. The readmission rates were 11.1% for 30-day readmissions and 
16.1% for 60-day readmissions and the ED/Obs visit rates were 10.7% within 30-days 
and 15.2% within 60-days.  In the matched sample, the HHC group had higher 
readmission rates for 30-day readmissions (14.6% [HHC]; 12.9%[non-HHC]) and 60-day 
readmissions at (20.1% [HHC]; 18.8% [non-HHC]) and for ED/Obs visits at 30-days 
(7.6% [HHC]; 6.6% [non-HHC]). and 60-days (HHC: 9.4% [HHC]; 8.9% [non-HHC]).  
Full and matched sample characteristics are included in  
Table 1. An expanded table reporting the rates adjusted for MDC and hospital fixed 
effects is available in Supplemental Digital Content: Effectiveness of HHC; Methods; 
Table 2. 
Of the 28 variables used in the matching process, there were residual differences 
with the matched samples on 6 variables (age, ICU days, payer [Private, Medicare, and 
Uninsured], SOI [Major, Extreme] and LOS). The HHC matched sample was older (67.4 
years [HHC];64.0 years [non-HHC], p<0.001), had longer ICU days (2.93 days [HHC]; 
2.06 days [non-HHC]),  had longer hospital LOS (6.25 days [HHC]; 5.8 days [non-HHC], 
p=0.02) had fewer private payers (21.7% [HHC]; 26.4% [non-HHC], p<0.00) and 
uninsured (0.48% [HHC]; 1.4% [non-HHC], p<0.001) payers, but more Medicare payers 
(58.9% [HHC]; 49.7% [non-HHC], p<0.00), and more patients with Major (41.4% 
[HHC], 38.7 [non-HHC], p=0.04) and Extreme (11.6% [HHC]; 9.9% [non-HHC], 





The unadjusted 2-sample tests and adjusted logit models comparing the matched 
samples of HHC and non-HHC patients indicated no significant differences between 
readmissions and ED/Obs visits within 30 and 60-days (See Table 2).   The full 
multinomial logit model including the MDC control variables is reported in the Digital 
Supplemental Content:  Effectiveness of HHC; Methods; Table 4. Post-hoc power 
analysis indicated an adequate sample size for 80% power to detect a 2 percentage point 
difference between HHC and non-HHC groups at p<.05 (25, 26).  
To further explore these findings, we stratified patients into high and low 
comorbidity groups using the Elixhauser Comorbidity Index (20) median score. In 
unadjusted and adjusted models, low-comorbidity patients receiving HHC had a 2.2 
percentage point higher rate of 30-day ED/Obs visits (7.3% [HHC]; 5.1% [non HHC], 
p<0.05). There were no statistically significant differences between HHC and non-HHC 
in readmission in low-comorbidity patients, or readmission and ED/Obs visits in high-
comorbidity patients (See Table 4).  Detailed results stratified by low and high-
comorbidities can be found in the Supplemental Digital Content:  Effectiveness of HHC; 
Table 4. 
DISCUSSION 
This study investigated the effectiveness of HHC in reducing readmissions and 
ED/Obs visits using a matched sample of patients with a broad range of clinical 
conditions discharged home from medical-surgical units of geographically diverse 
Magnet hospitals. There were no statistically significant differences in readmissions or 





patients were consistently higher by less than 2 percentage points in all comparisons.  
When stratified by comorbidity, we found that low-comorbidity patients with HHC had a 
2.2 percentage point higher rate of ED/Obs visits than those without HHC.  In these 
analyses, effectiveness in reducing readmissions was not evident. The differences 
between HHC and non-HHC were smaller than the rates reported in observational studies 
(10-13) but did not demonstrate the reductions observed with CHF specific home-visiting 
programs (14-16) While our results fall within the middle of the distribution of disease-
specific estimates, the consistently higher return to hospital rates for HHC patients versus 
non-HCC patients in our sample raises doubts about the overall effectiveness of HHC in 
preventing post-discharge returns to the hospital across all disease conditions.  
One possible explanation is that some readmissions and ED/Obs visits are 
unavoidable. For patients with high-comorbidities, disease progression can be expected 
and readmissions will occur.  Still, even among these patients, it is estimated that at least 
one-quarter of high-comorbidity readmissions can be considered preventable (27) . 
Studies have shown that home follow-up programs can reduce readmissions even in 
complex patients at high risk for readmission (16, 28-30).  In addition, we find in this 
study that differences in return to hospital rates are concentrated among low-comorbidity 
patients, who would be more likely to return to the hospital for preventable reasons than 
for unavoidable ones. For low-comorbidity patients, we found a statistically significant 
2.2 percentage point difference in ED/Obs visits for patients referred to HHC over non-
HHC patients.  We estimate a statistically insignificant 2.1 percentage point difference in 





no difference in ED/Obs visits among high-comorbidity patients and a much smaller, 
statistically insignificant 0.8 percentage point difference in readmissions.   
 Another possible explanation for our result is that HHC visits precipitate returns 
to the hospital.  Patients are more likely to visit the ED on days when the HHC nurse 
visits the home than on days without a nurse visit, a relationship that persists even among 
low-comorbidity patients (31).  Medico-legal concerns may underlie this pattern. When 
identifying a worsening clinical condition, HHC nurses face limited immediate treatment 
options and respond based on patient needs and nurse competencies for the situation (32).   
Leveraging the clinical skills of HHC providers and innovative interventions available to 
them may prevent returns to the hospital (33). Without timely access to necessary 
resources or situation-specific guidelines, nurses may recommend returning to the 
hospital to prevent negative health outcomes occurring at home (31).  As such, an HHC 
nurse may favor sending patients with symptom changes to the ED for treatment rather 
than risk possible ramifications of a negative outcome, particularly if the patient’s 
medical provider is not available for immediate consultation.   
Better training of HHC nurses and improved communication between HHC 
nurses and providers could reduce the frequency of readmissions and ED/Obs visits 
precipitated by HHC visits.  HHC agencies can create and implement programs that 
provide nurses with timely interventions and decision support tools aimed at preventing 
readmissions or ED/Obs visits, and, as the Identify, Triage, and Treat (ITT) team study 
has shown (34), these programs can be effective in improving outcomes and costs.  HHC 
agencies can also establish evening clinics, call centers, and/or health navigators for HHC 





Perhaps a reason why these programs have not been universally adopted is that 
incentives for better quality care have not always been aligned with an agency’s financial 
incentives. Although readmission is a prominent factor of home health quality reporting 
requirements, the current payment structure does not necessarily reward HHC agencies 
for preventing readmissions (33).  The introduction of Home Health Care Value-Based 
Purchasing (HHVBP) models, being tested by the Centers for Medicare and Medicaid 
Services (CMS) in nine states across the US to promote quality improvements for HHC 
agencies (35), will more closely align reimbursement with outcomes (7).  The new 
HHVBP will incentivize quality performance by shifting from volume-based to quality-
based payments with adjustments of up to 8 % (upward or downward) by 2022 in the 
pilot states.  
Additionally, the implementation of the Patient Driven Groupings Model 
(PDGM) in 2020 will more closely align treatment plans with HHC patients’ needs at the 
start of each payment episode (36). As specified, the PDGM incorporates HHC patients’ 
admission source, principal diagnosis, assessment-based functional impairment, and 
comorbidities from secondary diagnoses to group each HHC patient into a payment 
category, and it does so every 30 days to promote more timely adjustments to patients’ 
needs. If combined, a nationwide HHVBP model under the PDGM system could better 
align the financial incentives of HHC with quality performance. 
Strengths and Limitations 
This study extends prior research by evaluating the effectiveness of HHC in 





limitations to the design in this study.  First, by using an existing dataset, we were limited 
to using only those variables collected in the parent study.  HHC was identified as the 
presence of a referral.  We did not have data on actual occurrence of HHC visits, the 
number of visits, the content of those visits, or the quality of the match between patient 
and HHC agency.  Variables such as self-rating of health, communication challenges, 
HHC treatment plans (number and duration of visits, duration of treatment), and 
adherence to the prescribed treatment plans were not available.  The addition of these 
variables would be helpful to increase our understanding of the HHC processes impacting 
its effectiveness 
Despite efforts to account for referral bias through matching, the selection of 
patients for HHC from acute care may result in the referral of patients that are sicker than 
others representative of the community.  Additionally, some differences in patient 
characteristics were not possible to match. Acknowledging these limitations, we matched 
on as many variables as possible while still obtaining well-balanced matched samples.  
We successfully matched 82.5% of the available HHC patients. The HHC patients 
included in the matched sample had a slightly lower 30-day readmission rate than the full 
sample of patients referred to HHC (14.6% vs 15.9%), indicating some patients at high 
risk for readmission were omitted in the matching process. Consideration of additional or 
different variables may improve matching, and confidence in the study findings.  
 Finally, we were limited by the ability of participating hospitals to track only 
same-hospital readmissions.  Generally, hospitals capture and record readmissions 
occurring at the same site as the index admission; some systems are developing 





system (37).  A mean difference of 4.7% in readmissions between all-hospital and same-
hospital has been reported (37), and same hospital readmissions may not accurately 
predict all hospital readmissions (38).    Future studies using integrated data systems may 
be able to overcome this limitation.   
Conclusion 
In comparable HHC and non-HHC samples, patients had similar rates of 
readmission and ED/Obs visits.  This finding points to the need for examination of 
reasons for lack of effectiveness in reducing unplanned post-discharge utilization. With 
HHC reimbursement becoming increasingly linked to quality measure reporting and 
contributing to health system performance outcomes, prioritization of readmission 
avoidance as an HHC organizational outcome is an imperative.  HHC agencies will need 
to develop targeted care processes and decision support to improve their effectiveness in 
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Table 1:  Full and Matched Sample Characteristics 
       


















             
Outcome Variablesa             
30‐Day Readmission 2,088 578 1,510 397 350 0.24 
 (11.12) (15.93) (9.97) (14.61) (12.88)  
30‐Day ED/Obs Visit 2,006 397 1,609 207 179 0.27 
 (10.68) (10.94) (10.62) (7.62) (6.59)  
60‐Day Readmission 3,016 785 2,231 545 510 0.65 
 (16.06) (21.63) (14.73) (20.05) (18.76)  
60‐Day ED/Obs Visit 2,861 569 2,292 255 241 0.46 
 (15.24) (15.68) (15.13) (9.38) (8.87)  
Treatment Variablea             
HHC Referral 3,629 3,629 0 2,718 0 NA 
 (19.33) (100) (0) (100) (0)  
Matching Variables and 
Controls             
Interval-Scaled Variablesb             
Patient Age 59.31 57.22 68.01 67.42 64.03 0.00^^^ 
 (17.23) (17.08) (14.97) (14.76) (14.32)  
ICU Days 0.610 0.476 1.170 1.187 0.993 0.01 
 (1.89) (1.532) (2.88) (2.93) (2.06)  
Total Length of Stay 4.342 3.873 6.297 6.153 5.827 0.02 
 (3.91) (3.32) (5.32) (5.38) (4.29)  





 (8.65) (8.63) (8.68) (8.82) (8.84)  
Categorical Variablesa             
Female Gender 9,526 1,934 7,592 1,425 1,425 NA 
 (50.74) (53.29) (50.13) (52.43) (52.43)  
Non‐Hispanic Ethnicity 16,686 3,323 13,363 2,496 2,357 0.000 
 (88.88) (91.57) (88.23) (91.83) (86.72)  
Hispanic Ethnicity 1,716 287 1,429 207 239 0.11 
 (9.14) (7.91) (9.44) (7.62) (8.79)  
Unknown Ethnicity 372 19 353 15 122 0.000 
 (1.98) (0.52) (2.33) (0.55) (4.49)  
Black/African American 2,311 455 2,162 290 270 0.48 
 (12.31) (12.54) (14.28) (10.67) (9.93)  
Asian American 256 104 418 61 74 0.78 
 (1.36) (2.87) (2.76) (2.24) (2.72)  
Native American/Alaskan 522 10 246 6 7 0.26 
 (2.78) (0.28) (1.62) (0.22) (0.26)  
Hawaiian/Pacific Islander 2,617 19 27 18 7 0.37 
 (13.94) (0.52) (0.18) (0.66) (0.26)  
Unknown Race 46 442 1,869 317 334 0.03 
 (0.245) (12.18) (12.34) (11.66) (12.29)  
White Race 13,022 2,599 10,423 2,026 2,026 1.00 
 (69.36) (71.62) (68.82) (74.54) (74.54)  
30‐Day Prior Hospitalization 2,436 751 1,685 505 467 0.18 
 (12.98) (20.69) (11.13) (18.58) (17.18)  
31‐90‐Day Prior 
Hospitalization 1,505 390 1,115 227 265 1.00 
 (8.02) (10.75) (7.36) (8.35) (9.75)  
Minor Severity 2,380 156 2,224 124 173 0.00 
 (12.68) (4.30) (14.68) (4.56) (6.37)  
Moderate Severity 5,734 780 4,954 593 654 0.05 
 (30.54) (21.49) (32.71) (21.82) (24.06)  
Major Severity 5,763 1,491 4,272 1,126 1,051 0.04 





Extreme Severity 1,080 441 639 315 270 0.05 
 (5.75) (12.15) (4.22) (11.59) (9.93)  
Missing Severity 3,817 761 3,056 560 570 0.74 
 (20.33) (20.97) (20.18) (20.60) (20.97)  
Private Insurance 5,462 725 4,737 590 717 0.000 
 (29.09) (19.98) (31.28) (21.71) (26.38)  
Medicare 7,877 2,141 5,736 1,600 1,350 0.000 
 (41.96) (59.00) (37.87) (58.87) (49.67)  
Medicaid 2,787 339 2,448 253 311 0.01 
 (14.84) (9.34) (16.16) (9.31) (11.44)  
Uninsured 399 23 376 13 37 0.00 
 (2.13) (0.63) (2.48) (0.48) (1.36)  
Other Paytype 2,249 401 1,848 262 303 0.07 
 (11.98) (11.05) (12.20) (9.64) (11.15)  
Surgical Patient 5,116 1,122 3,994 841 841 1.00 
 (27.25) (30.92) (26.37) (30.94) (30.94)  
       
Observations 18,774 15,145 3,629 2,718  2,718    
a Reported as count (proportion).       
b Reported as mean (standard deviation).  




Table 2:  Post‐discharge return to hospital of matched samples with and without a Home Health 
Care referral 
   
  
30-Day                                      
Post-Discharge Utilization 











  Unadjusted Two‐Sample Test of Proportionsa 
     
HHC Referral Group 0.076 0.146 0.094 0.201 
 (0.0079) (0.0127) (0.0110) (0.0176) 
Matched Control 
Group 
0.066 0.129 0.089 0.188 
 (0.0065) (0.0154) (0.0106) (0.0210) 
Difference (HHC ‐ 
Control) 
0.010 0.017 0.005 0.013 
 (0.0091) (0.0143) (0.0111) (0.0170) 
     
  Adjusted Multinomial Logit Regressionb 
     
HHC Referral Group 0.078 0.145 0.095 0.199 
 (0.0069) (0.0127) (0.0083) (0.0161) 
Matched Control 
Group 
0.064 0.13 0.087 0.189 
 (0.0056) (0.0132) (0.0091) (0.0178) 
Difference (HHC ‐ 
Control) 
0.014 0.015 0.008 0.010 
 (0.0095) (0.0183) (0.0117) (0.0212) 
     
Control Variables         









ICU Days ‐0.002 ‐0.003 0.002 ‐0.008 
 (0.00235) (0.00272) (0.00434) (0.00472) 
Total Length of Stay 0.001 0.002 ‐0.001 0.004 
 (0.00103) ‐0.000949 (0.00191) (0.00183) 
High Risk (Elixhauser 
> 7) 
0.006 0.035** 0.010 0.038* 
 (0.00880) (0.0131) (0.00852) (0.0152) 
Hispanic Ethnicity 0.004 0.018 0.002 0.037 
 (0.0138) (0.0218) (0.0167) (0.0274) 
Unknown Ethnicity 0.024 ‐0.032 0.007 ‐0.071 
 (0.0144) (0.0301) (0.0187) (0.0373) 





Major 0.005 0.045* ‐0.004 0.052* 
 (0.00991) (0.0181) (0.0142) (0.0204) 
Extreme ‐0.002 0.070** ‐0.020 0.084** 
 (0.0119) (0.0222) (0.0195) (0.0239) 
Unknown Severity ‐0.010 0.056 ‐0.004 0.059 
 (0.0116) (0.0308) (0.0182) (0.0368) 
Pay Type (Base = 
Private) 
    
Medicare 0.003 0.022 0.005 0.040** 
 (0.0129) (0.0157) (0.0177) (0.0144) 
Medicaid 0.022 0.033 0.041 0.050 
 (0.0138) (0.0289) (0.0208) (0.0251) 
Uninsured 0.027 ‐0.012 0.034 ‐0.063 
 (0.0418) (0.0442) (0.0493) (0.0395) 
Other ‐0.020 0.022 ‐0.012 0.025 
 (0.0119) (0.0207) (0.0147) (0.0201) 
     
Observations 5,436    5,436    
a Reported as rates 
b Reported as marginal effects 
 
Standard errors in parentheses 
   




Table 3:  Post‐discharge return to hospital of matched samples with and without a Home Health 
Care referral stratified by low and high‐comorbidity 
 
     
  
30-Day                                      
Post-Discharge Utilization 











  Unadjusted Two‐Sample Test of Proportionsa 
     
HHC Referral Group    
 
  Low Comorbidity Risk 0.073 0.125 0.089 0.170 
 (0.0092) (0.0140) (0.0132) (0.0164) 
  High Comorbidity Risk 0.079 0.168 0.099 0.233 
 (0.00956) (0.0146) (0.0120) (0.0226) 
Matched Control Group     
  Low Comorbidity Risk 0.051 0.105 0.073 0.161 
 (0.0086) (0.0232) (0.0113) (0.0271) 
  High Comorbidity Risk 0.081 0.154 0.105 0.215 
 (0.0084) (0.0148) (0.0109) (0.0207) 
Difference (HHC ‐ 
Control) 
    
  Low Risk 0.022* 0.020 0.017 0.009 
 (0.0105) (0.0204) (0.0116) (0.0217) 
  High Risk ‐0.002 0.014 ‐0.007 0.0173 
 (0.0127) (0.0133) (0.0151) (0.0166) 
     
  Adjusted Multinomial Logit Regression  
     
HHC Referral Group     
  Low Comorbidity Risk 0.076 0.126 0.091 0.170 
 (0.00907) (0.0126) (0.0111) (0.0138) 
  High Comorbidity Risk 0.081 0.165 0.100 0.229 
 (0.00829) (0.0157) (0.00979) (0.0221) 
Matched Control Group     
  Low Comorbidity Risk 0.050 0.105 0.071 0.160 
 (0.00711) (0.0184) (0.00975) (0.0219) 
  High Comorbidity Risk 0.080 0.157 0.104 0.219 
 (0.00915) (0.0137) (0.0105) (0.0182) 
Difference (HHC ‐ 
Control) 
    
  Low Comorbidity Risk 0.026* 0.021 0.020 0.010 
 (0.0112) (0.0250) (0.0123) (0.0264) 
  High Comorbidity Risk 0.001 0.008 ‐0.005 0.011 





     
Control Variables         









ICU Days ‐0.002 ‐0.003 0.002 ‐0.008 
 (0.00234) (0.00271) (0.00436) (0.00472) 





Hispanic Ethnicity 0.003 0.017 0.002 0.037 
 (0.0133) (0.0218) (0.0163) (0.0273) 
Unknown Ethnicity 0.026* ‐0.031 0.009 ‐0.071 
 (0.0151) (0.0306) (0.0191) (0.0375) 
Severity Index (Base = Minor/Moderate)    
Major 0.004 0.045* ‐0.004 0.052* 
 (0.00995) (0.0182) (0.0142) (0.0205) 
Extreme ‐0.003 0.070** ‐0.020 0.084*** 
 (0.0120) (0.0221) (0.0196) (0.0239) 
Unknown Severity ‐0.010 0.056 ‐0.004 0.059 
 (0.0116) (0.0308) (0.0182) (0.0368) 
Pay Type (Base = 
Private) 
    
Medicare 0.003 0.022 0.005 0.040** 
 (0.0127) (0.0158) (0.0175) (0.0145) 
Medicaid 0.022 0.034 0.041 0.045 
 (0.0139) (0.0289) (0.0209) (0.0253) 
Uninsured 0.026 ‐0.012 0.034 ‐0.063 
 (0.0413) (0.0442) (0.0489) (0.0396) 
Other ‐0.019 0.022 ‐0.011 0.025 
 (0.0120) (0.0210) (0.0146) (0.0204) 
     
Observations 5,436    5,436    
a Reported as rates 
Standard errors in 
parentheses 
    
*** p<0.001, ** p<0.01, * p<0.05    
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Patient attributes contributing to receiving a referral to HHC prior to discharge 
from acute care has been discussed in the literature (19).  Despite several studies 
investigating which patient characteristics are most indicative for receiving a HHC 
referral, a definitive list remains elusive.  Certain characteristics such as age (39-43), 
functional status (40-43), and complex needs (39-43) identified as high-risk for receiving 
a HHC referral have a high level of agreement in studies. Other attributes, however, have 
less agreement such as frailty (44).  This study investigated 24 patient characteristics to 
identify those that were most indicative of receiving a HHC referral.   
Methods 
To identify patient characteristics that increase the likelihood of receiving a 
referral to Home Health Care (HHC), we used a correlational design to develop a 
propensity score model (21) reflecting the predicted probability of a HHC referral for 
each patient.  We then validated the propensity score model with a separate sample to be 
used to identify the effectiveness of HHC in reducing readmissions. 
Sample 
The sample (referral sample) consisted of 58,580 patients from the control 
(untreated) units from US hospitals (n=29) in the parent study who were discharged 
either with (n=11,491) or without (n=47,089) a referral to HHC.  Control unit patients 
were selected to avoid confounding by the intervention of the parent study in identifying 






The referral (1=referral/0=no referral) outcome variable was collected through the 
Electronic Health Record (EHR) data from the parent study database and derived from 
the hospital discharge disposition code. 
Patient characteristics variables were identified from the literature as indicative of 
receiving a referral to HHC (19).  Variables selected included Length of stay (LOS) 
[defined as the number of midnights in hospital categorized in quartiles], ICU days, 
Elixhauser comorbidity index (20), age (in years), prior readmissions (30 and 31-90-days 
from index admission),  severity of illness (SOI- including minor, moderate, major and 
extreme) from Diagnostic Related Groups [DRG], payer, medical/surgical patient type, 
sex (male/female), race (unknown, Native American/Alaskan, Asian American, 
Black/African American, Hawaiian/Pacific Islander, White, ethnicity (Hispanic, non-
Hispanic, unknown) and Major Diagnostic Category (MDC). 
Data Analysis 
We computed a logistic regression model to identify distinguishing patient 
characteristics that increase the likelihood of receiving a HHC referral.  Patient 
characteristics (24 total) variables were included in the analysis.  The following criteria 
were used to select variables that were both the statistically and clinically meaningful for 
inclusion a propensity score model for referral: 1) variables that were statistically 
significant (p = <0.05), 2) clinically meaningful with a marginal effect of 5%, and 3) the 
values remained consistent throughout the addition of controls into the model.  This 





included hospitalization characteristics. The second column added controls for patient 
characteristics.  The third column added hospital fixed effects.  A model that included 
MDC and hospital fixed effects can be seen in Table 2. 
A propensity score (21) for referral to HHC was estimated and calculated based 
on characteristics from the referral control sample. The propensity score was used as one 
of the distance matching variables for each patient in the effectiveness sample.  All 
analyses to calculate the propensity score were conducted using R version 3.4.3 (45).   
Results 
 The rate of referral to HHC prior to discharge was 19.6% (N=11,491).  
Readmission rates were 12.1% (referral full sample) for 30-day readmissions and 16.9% 
(referral full sample) for 31-60-day readmissions. The ED/Obs visits for the sample was 
lower (11.03%) at 30-days than at 31-60 days (15.3%). The full sample characteristics for 
the referral sample is included in Table 3.   
 During analysis, we found that 6 of 24 variables entered into the multivariate 
logistic regression met the predetermined criteria as statistically and clinically meaningful 
predictors of HHC referral: LOS, age, 30-day and 31-90-day prior admission from the 
index admission, SOI (major, extreme, and missing), and uninsured; their marginal 
effects on HHC referral are presented in Table 3.   
The test of the accuracy of the propensity score model developed with the referral 
sample and applied to the effectiveness sample produced an overall accuracy of 82.4%. 





of 80.8%; representing moderate discriminatory power (46).  The propensity score has a 
sensitivity of 22.4%, specificity of 96.8%, positive predictive value of 83.9%, and a 
negative predictive value of 62.6%.  
The entire model had a pseudo R2 of 0.06, indicating these patient characteristics 
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Table 1:  Patient Characteristics increasing the likelihood of receiving a referral to HHC including Major Diagnostic Category 
(MDC) and hospital fixed effects 
 
      
    Model 1 Model 2 Model 3  
  












           
Discharge HHC 0.196     
 (0.397)     
ICU Days 0.491 0.0055 0.0058* 0.0006 0.0009 
 (1.614) (0.0035) (0.0034) (0.0036)  
Total Length of Stay 4.172 0.0155*** 0.0159*** 0.0166*** 0.0675 
 (4.065) (0.0021) (0.0021) (0.0017)  
Elixhauser 7.077 0.0007 0.0008 0.0012*** 0.0100 
 (8.370) (0.0004) (0.0004) (0.0003)  
Age 60.74  0.0051*** 0.0050*** 0.0857 
 (17.10)  (0.0004) (0.0003)  
30-Day Prior Readmission 0.106 0.0929*** 0.0983*** 0.0866***  
 (0.308) (0.0180) (0.0166) (0.0075)  
31-90-Day Prior Readmission 0.0722 0.0672*** 0.0721*** 0.0667***  
 (0.259) (0.0133) (0.0121) (0.0105)  
Severity = Moderate 0.316 0.0418*** 0.0348*** 0.0315***  
 (0.465) (0.0086) (0.0087) (0.0072)  
Severity = Major 0.269 0.109*** 0.0984*** 0.0891***  
 (0.443) (0.0127) (0.0124) (0.0098)  
Severity = Extreme 0.0495 0.132*** 0.120*** 0.115***  
 (0.217) (0.0266) (0.0247) (0.0190)  
Severity = Missing 0.226 0.116** 0.0982** 0.0809***  
 (0.418) (0.0356) (0.0357) (0.0131)  





 (0.497) (0.0142) (0.0146) (0.0105)  
Paytype = Medicaid 0.156 -0.0153 0.0077 0.0152  
 (0.363) (0.0172) (0.0166) (0.0117)  
Paytype = Uninsured 0.0252 -0.0867** -0.0982** -0.0746*  
 (0.157) (0.0278) (0.0309) (0.0318)  
Paytype = Other 0.118 0.0271 0.0165 0.0044  
 (0.322) (0.0371) (0.0338) (0.0148)  
Surgical Patient 0.300 0.0136 0.0204 0.0337*  
 (0.458) (0.0211) (0.0206) (0.0143)  
Female  0.510  0.0239*** 0.0245***  
 (0.500)  (0.0072) (0.0065)  
Ethnicity = Hispanic 0.0819  -0.0032 -0.0245  
 (0.274)  (0.0124) (0.0129)  
Ethnicity = Unknown 0.0182  -0.0773 -0.0918  
 (0.134)  (0.0568) (0.0559)  
Race = Unknown 0.133  -0.0318   
 (0.340)  (0.0181)   
Race = Native American/Alaskan 0.0079  -0.0985**   
 (0.0886)  (0.0336)   
Race = Asian 0.0392  -0.0315   
 (0.194)  (0.0182)   
Race = Black/African American 0.167  0.0061   
 (0.373)  (0.0197)   
Race = Hawaiian/Pacific Islander 0.0041  -0.0253   
 (0.0636)  (0.0284)   
      
      
      
      
      
Eye 0.0022 -0.0912* -0.0946* -0.0764  
 (0.0469) (0.0429) (0.0430) (0.0480)  





 (0.111) (0.0254) (0.0255) (0.0253)  
Respiratory 0.103 -0.0061 -0.0210 -0.0136  
 (0.304) (0.0163) (0.0145) (0.0181)  
Circulatory 0.240 -0.0089 -0.0279 -0.0111  
 (0.427) (0.0268) (0.0234) (0.0236)  
Digestive 0.122 -0.0478** -0.0599*** -0.0668***  
 (0.327) (0.0161) (0.0153) (0.0194)  
Hepatobiliary & Pancreatic 0.0435 -0.0550** -0.0585** -0.0654**  
 (0.204) (0.0191) (0.0180) (0.0216)  
Musculoskeletal 0.0892 0.102** 0.0827* 0.0897**  
 (0.285) (0.0345) (0.0354) (0.0323)  
Skin & Subcutaneous 0.0302 0.0769*** 0.0752*** 0.0670***  
 (0.171) (0.0217) (0.0218) (0.0197)  
Endocrine & Metabolic 0.0367 0.0253 0.0313* 0.0271  
 (0.188) (0.0161) (0.0144) (0.0161)  
Kidney & Urinary 0.0619 0.0060 -0.0107 -0.0175  
 (0.241) (0.0170) (0.0152) (0.0188)  
Male Reproductive 0.0084 -0.0664 -0.0756* -0.0683  
 (0.0910) (0.0377) (0.0335) (0.0425)  
Female Reproductive 0.0165 -0.0466 -0.0510 -0.0552  
 (0.127) (0.0612) (0.0544) (0.0326)  
Pregnancy 0.0060 -0.139*** -0.0991* -0.0533  
 (0.0772) (0.0259) (0.0389) (0.0463)  
Blood & Immunological 0.0165 -0.0789*** -0.0775*** -0.0666**  
 (0.128) (0.0225) (0.0195) (0.0215)  
Meloproliferative Diseases 0.0053 -0.0886* -0.0905* -0.0557*  
 (0.0728) (0.0416) (0.0391) (0.0265)  
Infectious & Parasitic Diseases 0.0665 0.0433* 0.0386* 0.0335  
 (0.249) (0.0186) (0.0167) (0.0210)  
Mental 0.0022 -0.0517 -0.0635 -0.0442  
 (0.0472) (0.0422) (0.0378) (0.0311)  
Alcohol & Drug 0.0106 -0.121*** -0.110*** -0.116***  





Injury, Poison & Toxin 0.0147 -0.0191 -0.0080 -0.0074  
 (0.121) (0.0230) (0.0217) (0.0261)  
Other 0.0056 0.0162 0.0028 0.0093  
 (0.0743) (0.0278) (0.0272) (0.0275)  
Multiple Trauma 0.00241 -0.123*** -0.0944* -0.0445  
 (0.0490) (0.0346) (0.0458) (0.0500)  
HIV 0.0006 0.0581 0.103 0.140*  
 (0.0248) (0.0759) (0.0778) (0.0558)  
Transplants 0.0011 -0.0215 -0.0194 -0.0611  
 (0.0335) (0.0543) (0.0545) (0.0434)  
Unrelated 0.0074 -0.0191 -0.0253 -0.0225  
 (0.0859) (0.0218) (0.0226) (0.0268)  
Missing 0.0295 -0.0018 -0.0257 -0.0516  
 (0.169) (0.0305) (0.0245) (0.0283)  
a.hosp 0.0325   -0.176***  
 (0.177)   (0.0065)  
b.hosp 0.0370   0.0375*  
 (0.189)   (0.0153)  
c.hosp 0.0275   6.00e-05  
 (0.164)   (0.0234)  
d.hosp 0.0370   0.148***  
 (0.189)   (0.0177)  
e.hosp 0.0240   -0.121***  
 (0.153)   (0.0142)  
f.hosp 0.0306   0.0766***  
 (0.172)   (0.0193)  
g.hosp 0.0375   -0.0592***  
 (0.190)   (0.0109)  
h.hosp 0.0399   -0.0577***  
 (0.196)   (0.0112)  
i.hosp 0.0517   -0.0077  
 (0.221)   (0.0102)  





 (0.158)   (0.0098)  
k.hosp 0.0217   -0.198***  
 (0.146)   (0.0081)  
l.hosp 0.0458   -0.0901***  
 (0.209)   (0.0063)  
m.hosp 0.0206   0.0319  
 (0.142)   (0.0191)  
n.hosp 0.0202   -0.0774***  
 (0.141)   (0.0088)  
o.hosp 0.0779   -0.0909***  
 (0.268)   (0.0103)  
p.hosp 0.0224   -0.159***  
 (0.148)   (0.0066)  
q.hosp 0.0594   -0.0541***  
 (0.236)   (0.0145)  
r.hosp 0.0269   0.0844***  
 (0.162)   (0.0144)  
s.hosp 0.0382   0.0549***  
 (0.192)   (0.0131)  
t.hosp 0.0339   0.0209  
 (0.181)   (0.0159)  
u.hosp 0.0426   -0.0167  
 (0.202)   (0.0184)  
v.hosp 0.0490   -0.0158  
 (0.216)   (0.0129)  
w.hosp 0.0212   0.101***  
 (0.144)   (0.0184)  
x.hosp 0.0337   -0.0887***  
 (0.181)   (0.0154)  
y.hosp 0.0222   -0.0810***  
 (0.147)   (0.0125)  
z.hosp 0.0305   -0.0250*  





aa.hosp 0.0261   -0.0198  
 (0.159)   (0.0110)  
bb.hosp 0.0357   -0.0642***  
 (0.185)   (0.0137)  
      
Observations   58,580 58,580 58,580 
Clustered standard errors in parentheses    







Supplemental Digital Content:  Effectiveness of HHC; Methods 
 
Table 2 
Table 2:  Distribution by Major Diagnostic Category (MDC) and hospitals 
 
       





















             
Outcome Variablesa             
30-Day Readmission 2,088 578 1,510 397 350 0.238 
 (11.12) (15.93) (9.970) (14.61) (12.88)  
30-Day ED/Obs Visit 2,006 397 1,609 207 179 0.268 
 (10.68) (10.94) (10.62) (7.616) (6.586)  
60-Day Readmission 3,016 785 2,231 545 510 0.646 
 (16.06) (21.63) (14.73) (20.05) (18.76)  
60-Day ED/Obs Visit 2,861 569 2,292 255 241 0.456 
 (15.24) (15.68) (15.13) (9.382) (8.867)  
Treatment Variablea             
HHC Referral 3,629 3,629 0 2,718 0 NA 
 (19.33) (100) (0) (100) (0)  
Matching Variables and 
Controls             
Interval-Scaled Variablesb             
Patient Age 59.31 57.22 68.01 67.42 64.03 
0.0000^^
^ 
 (17.23) (17.08) (14.97) (14.76) (14.32)  
ICU Days 0.610 0.476 1.170 1.187 0.993 0.008 





Total Length of Stay 4.342 3.873 6.297 6.153 5.827 0.019 
 (3.906) (3.318) (5.315) (5.383) (4.287)  
Elixhauser Index 7.445 7.274 8.158 8.061 7.992 0.790 
 (8.646) (8.629) (8.682) (8.823) (8.839)  
Categorical Variablesa             
Female Gender 9,526 1,934 7,592 1,425 1,425 NA 
 (50.74) (53.29) (50.13) (52.43) (52.43)  
Non-Hispanic Ethnicity 16,686 3,323 13,363 2,496 2,357 
0.0000^^
^ 
 (88.88) (91.57) (88.23) (91.83) (86.72)  
Hispanic Ethnicity 1,716 287 1,429 207 239 0.114 
 (9.140) (7.909) (9.435) (7.616) (8.793)  
Unknown Ethnicity 372 19 353 15 122 
0.0000^^
^ 
 (1.981) (0.524) (2.331) (0.552) (4.489)  
Black/African American 2,311 455 2,162 290 270 0.478 
 (12.31) (12.54) (14.28) (10.67) (9.934)  
Asian American 256 104 418 61 74 0.781 
 (1.364) (2.866) (2.760) (2.244) (2.723)  
Native American/Alaskan 522 10 246 6 7 0.257 
 (2.780) (0.276) (1.624) (0.221) (0.258)  
Hawaiian/Pacific Islander 2,617 19 27 18 7 0.372 
 (13.94) (0.524) (0.178) (0.662) (0.258)  
Unknown Race 46 442 1,869 317 334 0.027 
 (0.245) (12.18) (12.34) (11.66) (12.29)  
White Race 13,022 2,599 10,423 2,026 2,026 1.0000 
 (69.36) (71.62) (68.82) (74.54) (74.54)  
30-Day Prior Hospitalization 2,436 751 1,685 505 467 0.179 
 (12.98) (20.69) (11.13) (18.58) (17.18)  
31-90-Day Prior Hospitalization† 1,505 390 1,115 227 265 1.0000 
 (8.016) (10.75) (7.362) (8.352) (9.750)  
Minor Severity 2,380 156 2,224 124 173 0.004 





Moderate Severity 5,734 780 4,954 593 654 0.049 
 (30.54) (21.49) (32.71) (21.82) (24.06)  
Major Severity 5,763 1,491 4,272 1,126 1,051 0.038 
 (30.70) (41.09) (28.21) (41.43) (38.67)  
Extreme Severity 1,080 441 639 315 270 0.049 
 (5.753) (12.15) (4.219) (11.59) (9.934)  
Missing Severity 3,817 761 3,056 560 570 0.738 
 (20.33) (20.97) (20.18) (20.60) (20.97)  
Private Insurance 5,462 725 4,737 590 717 0.0001 
 (29.09) (19.98) (31.28) (21.71) (26.38)  
Medicare 7,877 2,141 5,736 1,600 1,350 0.0000 
 (41.96) (59.00) (37.87) (58.87) (49.67)  
Medicaid 2,787 339 2,448 253 311 0.0099 
 (14.84) (9.341) (16.16) (9.308) (11.44)  
Uninsured 399 23 376 13 37 0.0006 
 (2.125) (0.634) (2.483) (0.478) (1.361)  
Other Paytype 2,249 401 1,848 262 303 0.068 
 (11.98) (11.05) (12.20) (9.639) (11.15)  
Surgical Patient 5,116 1,122 3,994 841 841 1.0000 
 (27.25) (30.92) (26.37) (30.94) (30.94)  
Nervous System 1,187 209 978 144 152 0.633 
 (6.323) (5.759) (6.458) (5.298) (5.592)  
Eye 20 3 17 2 3 0.655 
 (0.107) 
(0.0827
) (0.112) (0.0736) (0.110)  
ENT 225 31 194 23 15 0.193 
 (1.198) (0.854) (1.281) (0.846) (0.552)  
Respiratory 2,350 465 1,885 337 341 0.870 
 (12.52) (12.81) (12.45) (12.40) (12.55)  
Circulatory 3,322 956 2,366 757 698 0.071 
 (17.69) (26.34) (15.62) (27.85) (25.68)  
Digestive 2,605 307 2,298 223 286 0.003 





Hepatobiliary & Pancreatic 951 103 848 68 96 0.026 
 (5.066) (2.838) (5.599) (2.502) (3.532)  
Musculoskeletal 1,085 306 779 245 153 0.0000 
 (5.779) (8.432) (5.144) (9.014) (5.629)  
Skin & Subcutaneous 545 93 452 72 64 0.487 
 (2.903) (2.563) (2.984) (2.649) (2.355)  
Endocrine & Metabolic 1,016 108 908 80 118 0.006 
 (5.412) (2.976) (5.995) (2.943) (4.341)  
Kidney & Urinary 981 216 765 138 150 0.468 
 (5.225) (5.952) (5.051) (5.077) (5.519)  
Male Reproductive 99 13 86 10 9 0.818 
 (0.527) (0.358) (0.568) (0.368) (0.331)  
Female Reproductive 320 25 295 21 44 0.004 
 (1.704) (0.689) (1.948) (0.773) (1.619)  
Pregnancy 75 9 66 8 3 0.131 
 (0.399) (0.248) (0.436) (0.294) (0.110)  
Blood & Immunological 482 33 449 27 47 0.019 
 (2.567) (0.909) (2.965) (0.993) (1.729)  
Meloproliferative 62 4 58 2 24 0.0000 
 (0.330) (0.110) (0.383) (0.074) (0.883)  
Infectious & Parasitic 1,327 370 957 261 231 0.156 
 (7.068) (10.20) (6.319) (9.603) (8.499)  
Mental 31 7 24 4 3 0.705 
 (0.165) (0.193) (0.158) (0.147) (0.110)  
Alcohol & Drug 270 12 258 12 25 0.032 
 (1.438) (0.331) (1.704) (0.442) (0.920)  
Injury, Poison, & Toxin 274 52 222 36 24 0.119 
 (1.459) (1.433) (1.466) (1.325) (0.883)  
Other  102 18 84 14 11 0.548 
 (0.543) (0.496) (0.555) (0.515) (0.405)  
Multiple Trauma 32 5 27 5 9 0.285 
 (0.170) (0.138) (0.178) (0.184) (0.331)  





 (0.160) (0.165) (0.158) (0.184) (0.037)  
Transplants 58 40 18 37 16 0.003 
 (0.309) (1.102) (0.119) (1.361) (0.589)  
Unrelated Diagnosis 146 35 111 29 19 0.147 
 (0.778) (0.964) (0.733) (1.067) (0.699)  
Missing Diagnosis Code 1,179 203 976 158 176 0.309 
 (6.280) (5.594) (6.444) (5.813) (6.475)  
       
       
      
      
       
       
a.hosp 563 95 468 78 78  
 (2.999) (2.618) (3.090) (2.870) (2.870)  
b.hosp 878 33 845 25 25  
 (4.677) (0.909) (5.579) (0.920) (0.920)  
c.hosp 996 129 867 98 98  
 (5.305) (3.555) (5.725) (3.606) (3.606)  
d.hosp 463 130 333 87 87  
 (2.466) (3.582) (2.199) (3.201) (3.201)  
e.hosp 405 124 281 85 85  
 (2.157) (3.417) (1.855) (3.127) (3.127)  
f.hosp 342 47 295 33 33  
 (1.822) (1.295) (1.948) (1.214) (1.214)  
g.hosp 206 63 143 45 45  
 (1.097) (1.736) (0.944) (1.656) (1.656)  
h.hosp 776 137 639 110 110  
 (4.133) (3.775) (4.219) (4.047) (4.047)  
i.hosp 304 43 261 29 29  
 (1.619) (1.185) (1.723) (1.067) (1.067)  
j.hosp 408 68 340 40 40  





k.hosp 649 142 507 76 76  
 (3.457) (3.913) (3.348) (2.796) (2.796)  
l.hosp 370 23 347 18 18  
 (1.971) (0.634) (2.291) (0.662) (0.662)  
m.hosp 575 120 455 84 84  
 (3.063) (3.307) (3.004) (3.091) (3.091)  
n.hosp 794 144 650 129 129  
 (4.229) (3.968) (4.292) (4.746) (4.746)  
o.hosp 1,231 233 998 183 183  
 (6.557) (6.421) (6.590) (6.733) (6.733)  
p.hosp 690 82 608 69 69  
 (3.675) (2.260) (4.015) (2.539) (2.539)  
q.hosp 826 73 753 64 64  
 (4.400) (2.012) (4.972) (2.355) (2.355)  
r.hosp 740 123 617 84 84  
 (3.942) (3.389) (4.074) (3.091) (3.091)  
s.hosp 644 203 441 96 96  
 (3.430) (5.594) (2.912) (3.532) (3.532)  
t.hosp 749 194 555 163 163  
 (3.990) (5.346) (3.665) (5.997) (5.997)  
u.hosp 884 166 718 125 125  
 (4.709) (4.574) (4.741) (4.599) (4.599)  
v.hosp 823 268 555 244 244  
 (4.384) (7.385) (3.665) (8.977) (8.977)  
w.hosp 512 126 386 90 90  
 (2.727) (3.472) (2.549) (3.311) (3.311)  
x.hosp 500 316 184 261 261  
 (2.663) (8.708) (1.215) (9.603) (9.603)  
y.hosp 903 79 824 64 64  
 (4.810) (2.177) (5.441) (2.355) (2.355)  
z.hosp 580 114 466 80 80  
 (3.089) (3.141) (3.077) (2.943) (2.943)  





 (3.633) (2.866) (3.816) (3.017) (3.017)  
bb.hosp 614 112 502 94 94  
 (3.270) (3.086) (3.315) (3.458) (3.458)  
cc.hosp 667 138 529 82 82  




Observations 18,774 15,145 3,629 2,718  2,718    
a Reported as count (proportion).       
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Table 3 
Table 3: Post-discharge utilization of matched samples with and without a Home Health 
Care referral 
 
     
  
30-Day                                      
Post-Discharge Utilization 











  Unadjusted Two-Sample Test of Proportions 
     
HHC Referral Group 0.076 0.146 0.094 0.201 
 (0.008) (0.013) (0.011) (0.018) 
Matched Control 
Group 
0.066 0.129 0.089 0.188 
 (0.007) (0.015) (0.011) (0.021) 
Difference (HHC - 
Control) 
0.010 0.017 0.005 0.013 
 (0.009) (0.014) (0.011) (0.017) 
     
  Adjusted Multinomial Logit Regression 
     
HHC Referral Group 0.078 0.145 0.095 0.199 
 (0.007) (0.013) (0.008) (0.016) 
Matched Control 
Group 
0.064 0.13 0.087 0.189 
 (0.006) (0.013) (0.009) (0.018) 
Difference (HHC - 
Control) 
0.014 0.015 0.008 0.010 
 (0.010) (0.018) (0.012) (0.021) 
     
Control Variables         
Patient Age -8.60e-05 -0.001 4.32e-05 -0.001 
 (0.001) (0.001) (0.001) (0.001) 
ICU Days -0.002 -0.003 0.002 -0.008 
 (0.002) (0.003) (0.004) (0.005) 
Total Length of Stay 0.001 0.002 -0.001 0.004 
 (0.001) -0.001 (0.002) (0.002) 
High Risk 
(Elixhauser > 7) 
0.006 0.035** 0.010 0.038* 
 (0.009) (0.013) (0.009) (0.015) 
Hispanic Ethnicity 0.004 0.018 0.002 0.037 
 (0.012) (0.022) (0.017) (0.027) 





 (0.014) (0.030) (0.019) (0.037) 
Severity Index (Base = 
Minor/Moderate) 
   
Major 0.005 0.045* -0.004 0.052* 
 (0.010) (0.018) (0.014) (0.020) 
Extreme -0.002 0.070** -0.020 0.084** 
 (0.012) (0.022) (0.020) (0.024) 
Unknown Severity -0.010 0.056 -0.004 0.059 
 (0.012) (0.031) (0.018) (0.037) 
Pay Type (Base = 
Private) 
    
Medicare 0.003 0.022 0.005 0.040** 
 (0.013) (0.016) (0.018) (0.014) 
Medicaid 0.022 0.033 0.041 0.045 
 (0.014) (0.030) (0.021) (0.025) 
Uninsured 0.027 -0.012 0.034 -0.063 
 (0.042) (0.044) (0.049) (0.040) 
Other -0.020 0.022 -0.012 0.025 
 (0.012) (0.021) (0.015) (0.020) 
MDC Codes (Base = Alcohol & Drug) 
Eye 0.522* -0.108** 0.482 -0.134* 
 -0.263 (0.041) (0.255) (0.052) 
ENT 0.044 0.009 -0.002 0.013 
 (0.061) (0.084) (0.049) (0.096) 
Respiratory 0.021 0.039 0.009 0.085 
 (0.019) (0.042) (0.026) (0.053) 
Circulatory -0.016 0.040 -0.040* 0.059 
 (0.015) (0.039) (0.019) (0.050) 
Digestive 0.006 0.028 -0.028 0.088 
 (0.022) (0.042) (0.023) (0.053) 
Hepatobiliary & 
Pancreatic 
-0.006 0.061 -0.016 0.097 
 (0.026) (0.045) (0.028) (0.059) 
Musculoskeletal -0.026 -0.066 -0.059** -0.067 
 (0.020) (0.041) (0.020) (0.052) 
Skin & Subcutaneous 0.043 0.043 0.013 0.067 
 (0.042) (0.055) (0.044) (0.065) 
Endocrine & 
Metabolic 
0.039 0.025 0.023 0.078 
 (0.029) (0.053) (0.027) (0.063) 
Kidney & Urinary 0.064* 0.048 0.055 0.092 








 (0.015) (0.117) (0.017) (0.120) 





 (0.030) (0.060) (0.028) (0.067) 
Pregnancy 0.026 -0.024 0.076 -0.048 
 (0.087) (0.099) (0.088) (0.107) 
Blood & 
Immunological 
-0.012 0.122 -0.014 0.202* 
 (0.044) (0.072) (0.056) (0.089) 
Meloproliferative 
DD 
-0.002 -0.039 -0.037 -0.005 
 (0.079) (0.077) (0.080) (0.075) 
Infectious & Parasitic 
DD 
0.007 0.014 0.002 0.057 
 (0.019) (0.042) (0.023) (0.061) 
Mental 0.39 -0.108** 0.602** -0.134* 
 (0.204) (0.041) (0.186) (0.052) 
Alcohol & Drug 0.114 0.019 0.022 0.120 
 (0.059) (0.074) (0.057) (0.085) 
Injury, Poison, & 
Toxin 
0.016 0.016 0.027 0.037 
 (0.031) (0.063) (0.063) (0.076) 
Other 0.048 -0.025 0.007 0.109 
 (0.067) (0.054) (0.068) (0.074) 
Multiple Trauma 0.242 0.002 0.032 0.200 
 (0.231) (0.085) (0.082) (0.188) 
HIV 0.060 -0.108** 0.050 -0.134* 
 (0.128) (0.041) (0.137) (0.052) 
Transplants -0.049* 0.452** -0.088** 0.546** 
 (0.022) (0.137) (0.029) (0.168) 
Unrelated 0.044 0.054 0.016 0.061 
 (0.046) (0.058) (0.050) (0.083) 
Missing -0.021 0.016 -0.051 0.030 
 (0.018) (0.044) (0.032) (0.055) 
     
Observations 5,436    5,436    
Standard errors in 
parentheses 
    
*** p<0.001, ** p<0.01, * p<0.05    
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Table 4 
Table 4:  Post-discharge utilization of matched samples with and without a Home Health 
Care referral stratified by low and high-comorbidity 
     
  
30-Day                                      
Post-Discharge 
Utilization 












  Unadjusted Two-Sample Test of Proportions 
     
HHC Referral Group     
  Low Comorbidity Risk 0.073 0.125 0.089 0.170 
 (0.009) (0.014) (0.013) (0.016) 
  High Comorbidity Risk 0.079 0.168 0.099 0.233 
 (0.010) (0.015) (0.012) (0.023) 
Matched Control Group     
  Low Comorbidity Risk 0.051 0.105 0.073 0.161 
 (0.009) (0.023) (0.011) (0.027) 
  High Comorbidity Risk 0.081 0.154 0.105 0.215 
 (0.008) (0.015) (0.011) (0.021) 
Difference (HHC - 
Control) 
    
  Low Risk 0.022* 0.020 0.017 0.009 
 (0.011) (0.020) (0.012) (0.022) 
  High Risk -0.002 0.014 -0.007 0.017 
 (0.013) (0.013) (0.015) (0.017) 
     
  Adjusted Multinomial Logit Regression  
     
HHC Referral Group     
  Low Comorbidity Risk 0.076 0.126 0.091 0.170 
 (0.009) (0.013) (0.011) (0.014) 
  High Comorbidity Risk 0.081 0.165 0.010 0.229 
 (0.008) (0.016) (0.010) (0.022) 
Matched Control Group     
  Low Comorbidity Risk 0.050 0.105 0.071 0.160 
 (0.007) (0.018) (0.010) (0.022) 
  High Comorbidity Risk 0.080 0.157 0.104 0.219 
 (0.009) (0.014) (0.011) (0.018) 
Difference (HHC - 
Control) 
    
  Low Comorbidity Risk 0.026* 0.021 0.020 0.010 





  High Comorbidity Risk 0.001 0.008 -0.005 0.011 
 (0.013) (0.016) (0.016) (0.020) 
     








 (0.001) (0.001) (0.001) (0.001) 
ICU Days -0.002 -0.003 0.002 -0.008 
 (0.002) (0.003) (0.004) (0.005) 
Total Length of Stay 0.001 0.002 -0.001 0.004 
 (0.001) (0.001) (0.002) (0.002) 
Hispanic Ethnicity 0.003 0.017 0.002 0.037 
 (0.013) (0.022) (0.016) (0.027) 
Unknown Ethnicity 0.026* -0.031 0.009 -0.071 
 (0.015) (0.031 (0.019) (0.038) 
Severity Index (Base = 
Minor/Moderate) 
   
Major 0.004 0.045* -0.004 0.052* 
 (0.010) (0.018) (0.014) (0.021) 
Extreme -0.003 0.070** -0.020 
0.084**
* 
 (0.012) (0.022) (0.020) (0.024) 
Unknown Severity -0.010 0.056 -0.004 0.059 
 (0.012) (0.031) (0.018) (0.037) 
Pay Type (Base = 
Private) 
    
Medicare 0.003 0.022 0.005 0.040** 
 (0.013) (0.016) (0.018) (0.015) 
Medicaid 0.022 0.034 0.041 0.045 
 (0.014) (0.029) (0.021) (0.025) 
Uninsured 0.026 -0.012 0.034 -0.063 
 (0.041) (0.044) (0.049) (0.040) 
Other -0.019 0.022 -0.011 0.025 
 (0.012) (0.021) (0.015) (0.020) 
MDC Codes (Base = 
Alcohol & Drug) 





 (0.250) (0.041) (0.246) (0.052) 
ENT 0.042 0.008 -0.004 0.013 
 (0.061) (0.084) (0.049) (0.096) 
Respiratory 0.020 0.039 0.009 0.085 
 (0.019) (0.042) (0.026) (0.053) 
Circulatory -0.017 0.040 -0.040* 0.058 
 (0.015) (0.039) (0.019) (0.050) 





 (0.022) (0.042) (0.023) (0.053) 
Hepatobiliary & 
Pancreatic 
-0.006 0.061 -0.016 0.097 
 (0.027) (0.046) (0.028) (0.059) 




 (0.019) (0.041) (0.020) (0.052) 
Skin & Subcutaneous 0.042 0.043 0.012 0.067 
 (0.041) (0.055) (0.043) (0.065) 
Endocrine & Metabolic 0.040 0.025 0.023 0.078 
 (0.029) (0.053) (0.028) (0.063) 
Kidney & Urinary 0.062* 0.047 0.053 0.092 








 (0.015) (0.116) (0.017) (0.120) 




 (0.030) (0.060) (0.028) (0.067) 
Pregnancy 0.022 -0.025 0.070 -0.048 
 (0.082) (0.099) (0.086) (0.107) 
Blood & Immunological -0.012 0.122 -0.014 0.202* 
 (0.045) (0.072) (0.056) (0.089) 
Meloproliferative DD -0.000 -0.039 -0.036 -0.005 
 (0.079) (0.077) (0.080) (0.075) 
Infectious & Parasitic 
DD 
0.006 0.014 0.002 0.057 





 (0.195) (0.041) (0.186) (0.052) 
Alcohol & Drug 0.115 0.018 0.023 0.120 
 (0.059) (0.074) (0.058) (0.085) 
Injury, Poison, & Toxin 0.016 0.016 0.028 0.037 
 (0.031) (0.063) (0.064) (0.076) 
Other 0.046 -0.026 0.006 0.109 
 (0.066) (0.054) (0.067) (0.074) 
Multiple Trauma 0.240 0.002 0.031 0.200 





 (0.127) (0.041) (0.137) (0.052) 




 (0.022) (0.137) (0.029) (0.168) 





 (0.046) (0.058) (0.051) (0.083) 
Missing -0.022 0.016 -0.052 0.030 
 (0.017) (0.045) (0.032) (0.055) 
     
Observations 5,436    5,436    
Standard errors in 
parentheses 
    
*** p<0.001, ** p<0.01, * p<0.05    
 
